Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

No evidence of locus heterogeneity in familial microcephaly with or without chorioretinopathy, lymphedema, or mental retardation syndrome

Identifieur interne : 000D89 ( Pmc/Corpus ); précédent : 000D88; suivant : 000D90

No evidence of locus heterogeneity in familial microcephaly with or without chorioretinopathy, lymphedema, or mental retardation syndrome

Auteurs : Matthieu J. Schlögel ; Antonella Mendola ; Elodie Fastré ; Pradeep Vasudevan ; Koen Devriendt ; Thomy Jl De Ravel ; Hilde Van Esch ; Ingele Casteels ; Ignacio Arroyo Carrera ; Francesca Cristofoli ; Karen Fieggen ; Katheryn Jones ; Mark Lipson ; Irina Balikova ; Ami Singer ; Maria Soller ; María Mercedes Villanueva ; Nicole Revencu ; Laurence M. Boon ; Pascal Brouillard ; Miikka Vikkula

Source :

RBID : PMC:4464120

Abstract

Background

Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation syndrome (MCLMR) is a rare autosomal dominant disorder with variable expressivity. It is characterized by mild-to-severe microcephaly, often associated with intellectual disability, ocular defects and lymphedema. It can be sporadic or inherited. Eighty-seven patients have been described to carry a mutation in KIF11, which encodes a homotetrameric motor kinesin, EG5.

Methods

We tested 23 unreported MCLMR index patients for KIF11. We also reviewed the clinical phenotypes of all our patients as well as of those described in previously published studies.

Results

We identified 14 mutations, 12 of which are novel. We detected mutations in 12 affected individuals, from 6 out of 6 familial cases, and in 8 out of 17 sporadic patients. Phenotypic evaluation of patients (our 26 + 61 earlier published = 87) revealed microcephaly in 91%, eye anomalies in 72%, intellectual disability in 67% and lymphedema in 47% of the patients. Unaffected carriers were rare (4 out of 87: 5%). Family history is not a requisite for diagnosis; 31% (16 out of 52) were de novo cases.

Conclusions

All inherited cases, and 50% of sporadic cases of MCLMR are due to germline KIF11 mutations. It is possible that mosaic KIF11 mutations cause the remainder of sporadic cases, which the methods employed here were not designed to detect. On the other hand, some of them might have another mimicking disorder and genetic defect, as microcephaly is highly heterogeneous. In aggregate, KIF11 mutations likely cause the majority, if not all, of MCLMR.


Url:
DOI: 10.1186/s13023-015-0271-4
PubMed: 25934493
PubMed Central: 4464120

Links to Exploration step

PMC:4464120

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">No evidence of locus heterogeneity in familial microcephaly with or without chorioretinopathy, lymphedema, or mental retardation syndrome</title>
<author>
<name sortKey="Schlogel, Matthieu J" sort="Schlogel, Matthieu J" uniqKey="Schlogel M" first="Matthieu J" last="Schlögel">Matthieu J. Schlögel</name>
<affiliation>
<nlm:aff id="Aff1">Laboratory of Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Avenue Hippocrate 74, bte B1.74.06, B-1200 Brussels, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Mendola, Antonella" sort="Mendola, Antonella" uniqKey="Mendola A" first="Antonella" last="Mendola">Antonella Mendola</name>
<affiliation>
<nlm:aff id="Aff1">Laboratory of Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Avenue Hippocrate 74, bte B1.74.06, B-1200 Brussels, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Fastre, Elodie" sort="Fastre, Elodie" uniqKey="Fastre E" first="Elodie" last="Fastré">Elodie Fastré</name>
<affiliation>
<nlm:aff id="Aff1">Laboratory of Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Avenue Hippocrate 74, bte B1.74.06, B-1200 Brussels, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Vasudevan, Pradeep" sort="Vasudevan, Pradeep" uniqKey="Vasudevan P" first="Pradeep" last="Vasudevan">Pradeep Vasudevan</name>
<affiliation>
<nlm:aff id="Aff2">Department of Clinical Genetics, University Hospitals of Leicester, Leicester Royal Infirmary, Leicester, LE1 5WW UK</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Devriendt, Koen" sort="Devriendt, Koen" uniqKey="Devriendt K" first="Koen" last="Devriendt">Koen Devriendt</name>
<affiliation>
<nlm:aff id="Aff3">Center for Human Genetics, University Hospitals Leuven, KU Leuven, 3000 Leuven, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="De Ravel, Thomy Jl" sort="De Ravel, Thomy Jl" uniqKey="De Ravel T" first="Thomy Jl" last="De Ravel">Thomy Jl De Ravel</name>
<affiliation>
<nlm:aff id="Aff3">Center for Human Genetics, University Hospitals Leuven, KU Leuven, 3000 Leuven, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Van Esch, Hilde" sort="Van Esch, Hilde" uniqKey="Van Esch H" first="Hilde" last="Van Esch">Hilde Van Esch</name>
<affiliation>
<nlm:aff id="Aff3">Center for Human Genetics, University Hospitals Leuven, KU Leuven, 3000 Leuven, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Casteels, Ingele" sort="Casteels, Ingele" uniqKey="Casteels I" first="Ingele" last="Casteels">Ingele Casteels</name>
<affiliation>
<nlm:aff id="Aff4">Department of Ophthalmology, St Rafael University Hospitals, 3000 Leuven, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Arroyo Carrera, Ignacio" sort="Arroyo Carrera, Ignacio" uniqKey="Arroyo Carrera I" first="Ignacio" last="Arroyo Carrera">Ignacio Arroyo Carrera</name>
<affiliation>
<nlm:aff id="Aff5">Servicio de Pediatría, Hospital San Pedro de Alcántara, Cáceres, Spain</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Cristofoli, Francesca" sort="Cristofoli, Francesca" uniqKey="Cristofoli F" first="Francesca" last="Cristofoli">Francesca Cristofoli</name>
<affiliation>
<nlm:aff id="Aff3">Center for Human Genetics, University Hospitals Leuven, KU Leuven, 3000 Leuven, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Fieggen, Karen" sort="Fieggen, Karen" uniqKey="Fieggen K" first="Karen" last="Fieggen">Karen Fieggen</name>
<affiliation>
<nlm:aff id="Aff6">Division of Human Genetics, University of Cape Town, 7700 Cape Town, South Africa</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Jones, Katheryn" sort="Jones, Katheryn" uniqKey="Jones K" first="Katheryn" last="Jones">Katheryn Jones</name>
<affiliation>
<nlm:aff id="Aff7">Medical Genetics, Kaiser Permanente, Sacramento, CA 95815 USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Lipson, Mark" sort="Lipson, Mark" uniqKey="Lipson M" first="Mark" last="Lipson">Mark Lipson</name>
<affiliation>
<nlm:aff id="Aff7">Medical Genetics, Kaiser Permanente, Sacramento, CA 95815 USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Balikova, Irina" sort="Balikova, Irina" uniqKey="Balikova I" first="Irina" last="Balikova">Irina Balikova</name>
<affiliation>
<nlm:aff id="Aff8">Department of Ophthalmology, Queen Fabiola Children’s University Hospital (HUDERF), 1020 Brussels, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Singer, Ami" sort="Singer, Ami" uniqKey="Singer A" first="Ami" last="Singer">Ami Singer</name>
<affiliation>
<nlm:aff id="Aff9">Pediatrics and Medical Genetics, Barzilai Medical Center, 78306 Ashkelon, Israel</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Soller, Maria" sort="Soller, Maria" uniqKey="Soller M" first="Maria" last="Soller">Maria Soller</name>
<affiliation>
<nlm:aff id="Aff10">Department of Clinical Genetics, Lund University Hospital, 221 85 Lund, Sweden</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Mercedes Villanueva, Maria" sort="Mercedes Villanueva, Maria" uniqKey="Mercedes Villanueva M" first="María" last="Mercedes Villanueva">María Mercedes Villanueva</name>
<affiliation>
<nlm:aff id="Aff11">General Hospital of Florencio Varela, Children’s Hospital Dr. Pedro Elizalde and Foundation for Neurological Diseases of Childhood (FLENI), C1270AAN Buenos Aires, Capital Federal Argentina</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Revencu, Nicole" sort="Revencu, Nicole" uniqKey="Revencu N" first="Nicole" last="Revencu">Nicole Revencu</name>
<affiliation>
<nlm:aff id="Aff1">Laboratory of Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Avenue Hippocrate 74, bte B1.74.06, B-1200 Brussels, Belgium</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff12">Center for Human Genetics, Cliniques universitaires Saint-Luc, Université catholique de Louvain, 1200 Brussels, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Boon, Laurence M" sort="Boon, Laurence M" uniqKey="Boon L" first="Laurence M" last="Boon">Laurence M. Boon</name>
<affiliation>
<nlm:aff id="Aff1">Laboratory of Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Avenue Hippocrate 74, bte B1.74.06, B-1200 Brussels, Belgium</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff13">Center for Vascular Anomalies, Cliniques universitaires Saint-Luc, Université catholique de Louvain, 1200 Brussels, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Brouillard, Pascal" sort="Brouillard, Pascal" uniqKey="Brouillard P" first="Pascal" last="Brouillard">Pascal Brouillard</name>
<affiliation>
<nlm:aff id="Aff1">Laboratory of Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Avenue Hippocrate 74, bte B1.74.06, B-1200 Brussels, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Vikkula, Miikka" sort="Vikkula, Miikka" uniqKey="Vikkula M" first="Miikka" last="Vikkula">Miikka Vikkula</name>
<affiliation>
<nlm:aff id="Aff1">Laboratory of Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Avenue Hippocrate 74, bte B1.74.06, B-1200 Brussels, Belgium</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff13">Center for Vascular Anomalies, Cliniques universitaires Saint-Luc, Université catholique de Louvain, 1200 Brussels, Belgium</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff14">Walloon Excellence in Lifesciences and Biotechnology (WELBIO), Université catholique de Louvain, 1200 Brussels, Belgium</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">25934493</idno>
<idno type="pmc">4464120</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464120</idno>
<idno type="RBID">PMC:4464120</idno>
<idno type="doi">10.1186/s13023-015-0271-4</idno>
<date when="2015">2015</date>
<idno type="wicri:Area/Pmc/Corpus">000D89</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000D89</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">No evidence of locus heterogeneity in familial microcephaly with or without chorioretinopathy, lymphedema, or mental retardation syndrome</title>
<author>
<name sortKey="Schlogel, Matthieu J" sort="Schlogel, Matthieu J" uniqKey="Schlogel M" first="Matthieu J" last="Schlögel">Matthieu J. Schlögel</name>
<affiliation>
<nlm:aff id="Aff1">Laboratory of Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Avenue Hippocrate 74, bte B1.74.06, B-1200 Brussels, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Mendola, Antonella" sort="Mendola, Antonella" uniqKey="Mendola A" first="Antonella" last="Mendola">Antonella Mendola</name>
<affiliation>
<nlm:aff id="Aff1">Laboratory of Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Avenue Hippocrate 74, bte B1.74.06, B-1200 Brussels, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Fastre, Elodie" sort="Fastre, Elodie" uniqKey="Fastre E" first="Elodie" last="Fastré">Elodie Fastré</name>
<affiliation>
<nlm:aff id="Aff1">Laboratory of Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Avenue Hippocrate 74, bte B1.74.06, B-1200 Brussels, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Vasudevan, Pradeep" sort="Vasudevan, Pradeep" uniqKey="Vasudevan P" first="Pradeep" last="Vasudevan">Pradeep Vasudevan</name>
<affiliation>
<nlm:aff id="Aff2">Department of Clinical Genetics, University Hospitals of Leicester, Leicester Royal Infirmary, Leicester, LE1 5WW UK</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Devriendt, Koen" sort="Devriendt, Koen" uniqKey="Devriendt K" first="Koen" last="Devriendt">Koen Devriendt</name>
<affiliation>
<nlm:aff id="Aff3">Center for Human Genetics, University Hospitals Leuven, KU Leuven, 3000 Leuven, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="De Ravel, Thomy Jl" sort="De Ravel, Thomy Jl" uniqKey="De Ravel T" first="Thomy Jl" last="De Ravel">Thomy Jl De Ravel</name>
<affiliation>
<nlm:aff id="Aff3">Center for Human Genetics, University Hospitals Leuven, KU Leuven, 3000 Leuven, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Van Esch, Hilde" sort="Van Esch, Hilde" uniqKey="Van Esch H" first="Hilde" last="Van Esch">Hilde Van Esch</name>
<affiliation>
<nlm:aff id="Aff3">Center for Human Genetics, University Hospitals Leuven, KU Leuven, 3000 Leuven, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Casteels, Ingele" sort="Casteels, Ingele" uniqKey="Casteels I" first="Ingele" last="Casteels">Ingele Casteels</name>
<affiliation>
<nlm:aff id="Aff4">Department of Ophthalmology, St Rafael University Hospitals, 3000 Leuven, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Arroyo Carrera, Ignacio" sort="Arroyo Carrera, Ignacio" uniqKey="Arroyo Carrera I" first="Ignacio" last="Arroyo Carrera">Ignacio Arroyo Carrera</name>
<affiliation>
<nlm:aff id="Aff5">Servicio de Pediatría, Hospital San Pedro de Alcántara, Cáceres, Spain</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Cristofoli, Francesca" sort="Cristofoli, Francesca" uniqKey="Cristofoli F" first="Francesca" last="Cristofoli">Francesca Cristofoli</name>
<affiliation>
<nlm:aff id="Aff3">Center for Human Genetics, University Hospitals Leuven, KU Leuven, 3000 Leuven, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Fieggen, Karen" sort="Fieggen, Karen" uniqKey="Fieggen K" first="Karen" last="Fieggen">Karen Fieggen</name>
<affiliation>
<nlm:aff id="Aff6">Division of Human Genetics, University of Cape Town, 7700 Cape Town, South Africa</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Jones, Katheryn" sort="Jones, Katheryn" uniqKey="Jones K" first="Katheryn" last="Jones">Katheryn Jones</name>
<affiliation>
<nlm:aff id="Aff7">Medical Genetics, Kaiser Permanente, Sacramento, CA 95815 USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Lipson, Mark" sort="Lipson, Mark" uniqKey="Lipson M" first="Mark" last="Lipson">Mark Lipson</name>
<affiliation>
<nlm:aff id="Aff7">Medical Genetics, Kaiser Permanente, Sacramento, CA 95815 USA</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Balikova, Irina" sort="Balikova, Irina" uniqKey="Balikova I" first="Irina" last="Balikova">Irina Balikova</name>
<affiliation>
<nlm:aff id="Aff8">Department of Ophthalmology, Queen Fabiola Children’s University Hospital (HUDERF), 1020 Brussels, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Singer, Ami" sort="Singer, Ami" uniqKey="Singer A" first="Ami" last="Singer">Ami Singer</name>
<affiliation>
<nlm:aff id="Aff9">Pediatrics and Medical Genetics, Barzilai Medical Center, 78306 Ashkelon, Israel</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Soller, Maria" sort="Soller, Maria" uniqKey="Soller M" first="Maria" last="Soller">Maria Soller</name>
<affiliation>
<nlm:aff id="Aff10">Department of Clinical Genetics, Lund University Hospital, 221 85 Lund, Sweden</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Mercedes Villanueva, Maria" sort="Mercedes Villanueva, Maria" uniqKey="Mercedes Villanueva M" first="María" last="Mercedes Villanueva">María Mercedes Villanueva</name>
<affiliation>
<nlm:aff id="Aff11">General Hospital of Florencio Varela, Children’s Hospital Dr. Pedro Elizalde and Foundation for Neurological Diseases of Childhood (FLENI), C1270AAN Buenos Aires, Capital Federal Argentina</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Revencu, Nicole" sort="Revencu, Nicole" uniqKey="Revencu N" first="Nicole" last="Revencu">Nicole Revencu</name>
<affiliation>
<nlm:aff id="Aff1">Laboratory of Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Avenue Hippocrate 74, bte B1.74.06, B-1200 Brussels, Belgium</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff12">Center for Human Genetics, Cliniques universitaires Saint-Luc, Université catholique de Louvain, 1200 Brussels, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Boon, Laurence M" sort="Boon, Laurence M" uniqKey="Boon L" first="Laurence M" last="Boon">Laurence M. Boon</name>
<affiliation>
<nlm:aff id="Aff1">Laboratory of Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Avenue Hippocrate 74, bte B1.74.06, B-1200 Brussels, Belgium</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff13">Center for Vascular Anomalies, Cliniques universitaires Saint-Luc, Université catholique de Louvain, 1200 Brussels, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Brouillard, Pascal" sort="Brouillard, Pascal" uniqKey="Brouillard P" first="Pascal" last="Brouillard">Pascal Brouillard</name>
<affiliation>
<nlm:aff id="Aff1">Laboratory of Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Avenue Hippocrate 74, bte B1.74.06, B-1200 Brussels, Belgium</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Vikkula, Miikka" sort="Vikkula, Miikka" uniqKey="Vikkula M" first="Miikka" last="Vikkula">Miikka Vikkula</name>
<affiliation>
<nlm:aff id="Aff1">Laboratory of Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Avenue Hippocrate 74, bte B1.74.06, B-1200 Brussels, Belgium</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff13">Center for Vascular Anomalies, Cliniques universitaires Saint-Luc, Université catholique de Louvain, 1200 Brussels, Belgium</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="Aff14">Walloon Excellence in Lifesciences and Biotechnology (WELBIO), Université catholique de Louvain, 1200 Brussels, Belgium</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Orphanet Journal of Rare Diseases</title>
<idno type="eISSN">1750-1172</idno>
<imprint>
<date when="2015">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<sec>
<title>Background</title>
<p>Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation syndrome (MCLMR) is a rare autosomal dominant disorder with variable expressivity. It is characterized by mild-to-severe microcephaly, often associated with intellectual disability, ocular defects and lymphedema. It can be sporadic or inherited. Eighty-seven patients have been described to carry a mutation in
<italic>KIF11</italic>
, which encodes a homotetrameric motor kinesin, EG5.</p>
</sec>
<sec>
<title>Methods</title>
<p>We tested 23 unreported MCLMR index patients for
<italic>KIF11</italic>
. We also reviewed the clinical phenotypes of all our patients as well as of those described in previously published studies.</p>
</sec>
<sec>
<title>Results</title>
<p>We identified 14 mutations, 12 of which are novel. We detected mutations in 12 affected individuals, from 6 out of 6 familial cases, and in 8 out of 17 sporadic patients. Phenotypic evaluation of patients (our 26 + 61 earlier published = 87) revealed microcephaly in 91%, eye anomalies in 72%, intellectual disability in 67% and lymphedema in 47% of the patients. Unaffected carriers were rare (4 out of 87: 5%). Family history is not a requisite for diagnosis; 31% (16 out of 52) were
<italic>de novo</italic>
cases.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>All inherited cases, and 50% of sporadic cases of MCLMR are due to germline
<italic>KIF11</italic>
mutations. It is possible that mosaic
<italic>KIF11</italic>
mutations cause the remainder of sporadic cases, which the methods employed here were not designed to detect. On the other hand, some of them might have another mimicking disorder and genetic defect, as microcephaly is highly heterogeneous. In aggregate,
<italic>KIF11</italic>
mutations likely cause the majority, if not all, of MCLMR.</p>
</sec>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct>
<analytic>
<author>
<name sortKey="Mckusick, Va" uniqKey="Mckusick V">VA McKusick</name>
</author>
<author>
<name sortKey="Stauffer, M" uniqKey="Stauffer M">M Stauffer</name>
</author>
<author>
<name sortKey="Knox, Dl" uniqKey="Knox D">DL Knox</name>
</author>
<author>
<name sortKey="Clark, Db" uniqKey="Clark D">DB Clark</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Vasudevan, Pc" uniqKey="Vasudevan P">PC Vasudevan</name>
</author>
<author>
<name sortKey="Garcia Minaur, S" uniqKey="Garcia Minaur S">S Garcia-Minaur</name>
</author>
<author>
<name sortKey="Botella, Mp" uniqKey="Botella M">MP Botella</name>
</author>
<author>
<name sortKey="Perez Aytes, A" uniqKey="Perez Aytes A">A Perez-Aytes</name>
</author>
<author>
<name sortKey="Shannon, Nl" uniqKey="Shannon N">NL Shannon</name>
</author>
<author>
<name sortKey="Quarrell, Ow" uniqKey="Quarrell O">OW Quarrell</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Eventov Friedman, S" uniqKey="Eventov Friedman S">S Eventov-Friedman</name>
</author>
<author>
<name sortKey="Singer, A" uniqKey="Singer A">A Singer</name>
</author>
<author>
<name sortKey="Shinwell, Es" uniqKey="Shinwell E">ES Shinwell</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gupta, A" uniqKey="Gupta A">A Gupta</name>
</author>
<author>
<name sortKey="Vasudevan, P" uniqKey="Vasudevan P">P Vasudevan</name>
</author>
<author>
<name sortKey="Biswas, S" uniqKey="Biswas S">S Biswas</name>
</author>
<author>
<name sortKey="Smith, Jc" uniqKey="Smith J">JC Smith</name>
</author>
<author>
<name sortKey="Moore, At" uniqKey="Moore A">AT Moore</name>
</author>
<author>
<name sortKey="Lloyd, C" uniqKey="Lloyd C">C Lloyd</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Lee, Bj" uniqKey="Lee B">BJ Lee</name>
</author>
<author>
<name sortKey="Kim, Jh" uniqKey="Kim J">JH Kim</name>
</author>
<author>
<name sortKey="Yu, Ys" uniqKey="Yu Y">YS Yu</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ostergaard, P" uniqKey="Ostergaard P">P Ostergaard</name>
</author>
<author>
<name sortKey="Simpson, Ma" uniqKey="Simpson M">MA Simpson</name>
</author>
<author>
<name sortKey="Mendola, A" uniqKey="Mendola A">A Mendola</name>
</author>
<author>
<name sortKey="Vasudevan, P" uniqKey="Vasudevan P">P Vasudevan</name>
</author>
<author>
<name sortKey="Connell, Fc" uniqKey="Connell F">FC Connell</name>
</author>
<author>
<name sortKey="Van Impel, A" uniqKey="Van Impel A">A van Impel</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Robitaille, Jm" uniqKey="Robitaille J">JM Robitaille</name>
</author>
<author>
<name sortKey="Gillett, Rm" uniqKey="Gillett R">RM Gillett</name>
</author>
<author>
<name sortKey="Leblanc, Ma" uniqKey="Leblanc M">MA LeBlanc</name>
</author>
<author>
<name sortKey="Gaston, D" uniqKey="Gaston D">D Gaston</name>
</author>
<author>
<name sortKey="Nightingale, M" uniqKey="Nightingale M">M Nightingale</name>
</author>
<author>
<name sortKey="Mackley, Mp" uniqKey="Mackley M">MP Mackley</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Hazan, F" uniqKey="Hazan F">F Hazan</name>
</author>
<author>
<name sortKey="Ostergaard, P" uniqKey="Ostergaard P">P Ostergaard</name>
</author>
<author>
<name sortKey="Ozturk, T" uniqKey="Ozturk T">T Ozturk</name>
</author>
<author>
<name sortKey="Kantekin, E" uniqKey="Kantekin E">E Kantekin</name>
</author>
<author>
<name sortKey="Atlihan, F" uniqKey="Atlihan F">F Atlihan</name>
</author>
<author>
<name sortKey="Jeffery, S" uniqKey="Jeffery S">S Jeffery</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Jones, Ge" uniqKey="Jones G">GE Jones</name>
</author>
<author>
<name sortKey="Ostergaard, P" uniqKey="Ostergaard P">P Ostergaard</name>
</author>
<author>
<name sortKey="Moore, At" uniqKey="Moore A">AT Moore</name>
</author>
<author>
<name sortKey="Connell, Fc" uniqKey="Connell F">FC Connell</name>
</author>
<author>
<name sortKey="Williams, D" uniqKey="Williams D">D Williams</name>
</author>
<author>
<name sortKey="Quarrell, O" uniqKey="Quarrell O">O Quarrell</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Mirzaa, Gm" uniqKey="Mirzaa G">GM Mirzaa</name>
</author>
<author>
<name sortKey="Enyedi, L" uniqKey="Enyedi L">L Enyedi</name>
</author>
<author>
<name sortKey="Parsons, G" uniqKey="Parsons G">G Parsons</name>
</author>
<author>
<name sortKey="Collins, S" uniqKey="Collins S">S Collins</name>
</author>
<author>
<name sortKey="Medne, L" uniqKey="Medne L">L Medne</name>
</author>
<author>
<name sortKey="Adams, C" uniqKey="Adams C">C Adams</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Le Guellec, R" uniqKey="Le Guellec R">R Le Guellec</name>
</author>
<author>
<name sortKey="Paris, J" uniqKey="Paris J">J Paris</name>
</author>
<author>
<name sortKey="Couturier, A" uniqKey="Couturier A">A Couturier</name>
</author>
<author>
<name sortKey="Roghi, C" uniqKey="Roghi C">C Roghi</name>
</author>
<author>
<name sortKey="Philippe, M" uniqKey="Philippe M">M Philippe</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Casteels, I" uniqKey="Casteels I">I Casteels</name>
</author>
<author>
<name sortKey="Devriendt, K" uniqKey="Devriendt K">K Devriendt</name>
</author>
<author>
<name sortKey="Van Cleynenbreugel, H" uniqKey="Van Cleynenbreugel H">H Van Cleynenbreugel</name>
</author>
<author>
<name sortKey="Demaerel, P" uniqKey="Demaerel P">P Demaerel</name>
</author>
<author>
<name sortKey="De Tavernier, F" uniqKey="De Tavernier F">F De Tavernier</name>
</author>
<author>
<name sortKey="Fryns, Jp" uniqKey="Fryns J">JP Fryns</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Young, Id" uniqKey="Young I">ID Young</name>
</author>
<author>
<name sortKey="Fielder, Ar" uniqKey="Fielder A">AR Fielder</name>
</author>
<author>
<name sortKey="Simpson, K" uniqKey="Simpson K">K Simpson</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Fryns, Jp" uniqKey="Fryns J">JP Fryns</name>
</author>
<author>
<name sortKey="Smeets, E" uniqKey="Smeets E">E Smeets</name>
</author>
<author>
<name sortKey="Van Den Berghe, H" uniqKey="Van Den Berghe H">H Van den Berghe</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wildeman, M" uniqKey="Wildeman M">M Wildeman</name>
</author>
<author>
<name sortKey="Van Ophuizen, E" uniqKey="Van Ophuizen E">E van Ophuizen</name>
</author>
<author>
<name sortKey="Den Dunnen, Jt" uniqKey="Den Dunnen J">JT den Dunnen</name>
</author>
<author>
<name sortKey="Taschner, Pe" uniqKey="Taschner P">PE Taschner</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sherry, St" uniqKey="Sherry S">ST Sherry</name>
</author>
<author>
<name sortKey="Ward, Mh" uniqKey="Ward M">MH Ward</name>
</author>
<author>
<name sortKey="Kholodov, M" uniqKey="Kholodov M">M Kholodov</name>
</author>
<author>
<name sortKey="Baker, J" uniqKey="Baker J">J Baker</name>
</author>
<author>
<name sortKey="Phan, L" uniqKey="Phan L">L Phan</name>
</author>
<author>
<name sortKey="Smigielski, Em" uniqKey="Smigielski E">EM Smigielski</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Adzhubei, Ia" uniqKey="Adzhubei I">IA Adzhubei</name>
</author>
<author>
<name sortKey="Schmidt, S" uniqKey="Schmidt S">S Schmidt</name>
</author>
<author>
<name sortKey="Peshkin, L" uniqKey="Peshkin L">L Peshkin</name>
</author>
<author>
<name sortKey="Ramensky, Ve" uniqKey="Ramensky V">VE Ramensky</name>
</author>
<author>
<name sortKey="Gerasimova, A" uniqKey="Gerasimova A">A Gerasimova</name>
</author>
<author>
<name sortKey="Bork, P" uniqKey="Bork P">P Bork</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ng, Pc" uniqKey="Ng P">PC Ng</name>
</author>
<author>
<name sortKey="Henikoff, S" uniqKey="Henikoff S">S Henikoff</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Schwarz, Jm" uniqKey="Schwarz J">JM Schwarz</name>
</author>
<author>
<name sortKey="Rodelsperger, C" uniqKey="Rodelsperger C">C Rodelsperger</name>
</author>
<author>
<name sortKey="Schuelke, M" uniqKey="Schuelke M">M Schuelke</name>
</author>
<author>
<name sortKey="Seelow, D" uniqKey="Seelow D">D Seelow</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kuechler, A" uniqKey="Kuechler A">A Kuechler</name>
</author>
<author>
<name sortKey="Willemsen, Mh" uniqKey="Willemsen M">MH Willemsen</name>
</author>
<author>
<name sortKey="Albrecht, B" uniqKey="Albrecht B">B Albrecht</name>
</author>
<author>
<name sortKey="Bacino, Ca" uniqKey="Bacino C">CA Bacino</name>
</author>
<author>
<name sortKey="Bartholomew, Dw" uniqKey="Bartholomew D">DW Bartholomew</name>
</author>
<author>
<name sortKey="Van Bokhoven, H" uniqKey="Van Bokhoven H">H van Bokhoven</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sohal, Ap" uniqKey="Sohal A">AP Sohal</name>
</author>
<author>
<name sortKey="Montgomery, T" uniqKey="Montgomery T">T Montgomery</name>
</author>
<author>
<name sortKey="Mitra, D" uniqKey="Mitra D">D Mitra</name>
</author>
<author>
<name sortKey="Ramesh, V" uniqKey="Ramesh V">V Ramesh</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Brouillard, P" uniqKey="Brouillard P">P Brouillard</name>
</author>
<author>
<name sortKey="Boon, L" uniqKey="Boon L">L Boon</name>
</author>
<author>
<name sortKey="Vikkula, M" uniqKey="Vikkula M">M Vikkula</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ghalamkarpour, A" uniqKey="Ghalamkarpour A">A Ghalamkarpour</name>
</author>
<author>
<name sortKey="Debauche, C" uniqKey="Debauche C">C Debauche</name>
</author>
<author>
<name sortKey="Haan, E" uniqKey="Haan E">E Haan</name>
</author>
<author>
<name sortKey="Van Regemorter, N" uniqKey="Van Regemorter N">N Van Regemorter</name>
</author>
<author>
<name sortKey="Sznajer, Y" uniqKey="Sznajer Y">Y Sznajer</name>
</author>
<author>
<name sortKey="Thomas, D" uniqKey="Thomas D">D Thomas</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Irrthum, A" uniqKey="Irrthum A">A Irrthum</name>
</author>
<author>
<name sortKey="Devriendt, K" uniqKey="Devriendt K">K Devriendt</name>
</author>
<author>
<name sortKey="Chitayat, D" uniqKey="Chitayat D">D Chitayat</name>
</author>
<author>
<name sortKey="Matthijs, G" uniqKey="Matthijs G">G Matthijs</name>
</author>
<author>
<name sortKey="Glade, C" uniqKey="Glade C">C Glade</name>
</author>
<author>
<name sortKey="Steijlen, Pm" uniqKey="Steijlen P">PM Steijlen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Von Der Hagen, M" uniqKey="Von Der Hagen M">M von der Hagen</name>
</author>
<author>
<name sortKey="Pivarcsi, M" uniqKey="Pivarcsi M">M Pivarcsi</name>
</author>
<author>
<name sortKey="Liebe, J" uniqKey="Liebe J">J Liebe</name>
</author>
<author>
<name sortKey="Von Bernuth, H" uniqKey="Von Bernuth H">H von Bernuth</name>
</author>
<author>
<name sortKey="Didonato, N" uniqKey="Didonato N">N Didonato</name>
</author>
<author>
<name sortKey="Hennermann, Jb" uniqKey="Hennermann J">JB Hennermann</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Schlogel, Mj" uniqKey="Schlogel M">MJ Schlögel</name>
</author>
<author>
<name sortKey="Brouillard, P" uniqKey="Brouillard P">P Brouillard</name>
</author>
<author>
<name sortKey="Boon, Lm" uniqKey="Boon L">LM Boon</name>
</author>
<author>
<name sortKey="Vikkula, M" uniqKey="Vikkula M">M Vikkula</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Douzgou, S" uniqKey="Douzgou S">S Douzgou</name>
</author>
<author>
<name sortKey="Petersen, Mb" uniqKey="Petersen M">MB Petersen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Brouillard, P" uniqKey="Brouillard P">P Brouillard</name>
</author>
<author>
<name sortKey="Boon, Lm" uniqKey="Boon L">LM Boon</name>
</author>
<author>
<name sortKey="Mulliken, Jb" uniqKey="Mulliken J">JB Mulliken</name>
</author>
<author>
<name sortKey="Enjolras, O" uniqKey="Enjolras O">O Enjolras</name>
</author>
<author>
<name sortKey="Ghassibe, M" uniqKey="Ghassibe M">M Ghassibe</name>
</author>
<author>
<name sortKey="Warman, Ml" uniqKey="Warman M">ML Warman</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Amyere, M" uniqKey="Amyere M">M Amyere</name>
</author>
<author>
<name sortKey="Aerts, V" uniqKey="Aerts V">V Aerts</name>
</author>
<author>
<name sortKey="Brouillard, P" uniqKey="Brouillard P">P Brouillard</name>
</author>
<author>
<name sortKey="Mcintyre, Ba" uniqKey="Mcintyre B">BA McIntyre</name>
</author>
<author>
<name sortKey="Duhoux, Fp" uniqKey="Duhoux F">FP Duhoux</name>
</author>
<author>
<name sortKey="Wassef, M" uniqKey="Wassef M">M Wassef</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Limaye, N" uniqKey="Limaye N">N Limaye</name>
</author>
<author>
<name sortKey="Wouters, V" uniqKey="Wouters V">V Wouters</name>
</author>
<author>
<name sortKey="Uebelhoer, M" uniqKey="Uebelhoer M">M Uebelhoer</name>
</author>
<author>
<name sortKey="Tuominen, M" uniqKey="Tuominen M">M Tuominen</name>
</author>
<author>
<name sortKey="Wirkkala, R" uniqKey="Wirkkala R">R Wirkkala</name>
</author>
<author>
<name sortKey="Mulliken, Jb" uniqKey="Mulliken J">JB Mulliken</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Parke, Cl" uniqKey="Parke C">CL Parke</name>
</author>
<author>
<name sortKey="Wojcik, Ej" uniqKey="Wojcik E">EJ Wojcik</name>
</author>
<author>
<name sortKey="Kim, S" uniqKey="Kim S">S Kim</name>
</author>
<author>
<name sortKey="Worthylake, Dk" uniqKey="Worthylake D">DK Worthylake</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sawin, Ke" uniqKey="Sawin K">KE Sawin</name>
</author>
<author>
<name sortKey="Mitchison, Tj" uniqKey="Mitchison T">TJ Mitchison</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Rapley, J" uniqKey="Rapley J">J Rapley</name>
</author>
<author>
<name sortKey="Nicolas, M" uniqKey="Nicolas M">M Nicolas</name>
</author>
<author>
<name sortKey="Groen, A" uniqKey="Groen A">A Groen</name>
</author>
<author>
<name sortKey="Regue, L" uniqKey="Regue L">L Regue</name>
</author>
<author>
<name sortKey="Bertran, Mt" uniqKey="Bertran M">MT Bertran</name>
</author>
<author>
<name sortKey="Caelles, C" uniqKey="Caelles C">C Caelles</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Bertran, Mt" uniqKey="Bertran M">MT Bertran</name>
</author>
<author>
<name sortKey="Sdelci, S" uniqKey="Sdelci S">S Sdelci</name>
</author>
<author>
<name sortKey="Regue, L" uniqKey="Regue L">L Regue</name>
</author>
<author>
<name sortKey="Avruch, J" uniqKey="Avruch J">J Avruch</name>
</author>
<author>
<name sortKey="Caelles, C" uniqKey="Caelles C">C Caelles</name>
</author>
<author>
<name sortKey="Roig, J" uniqKey="Roig J">J Roig</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ferenz, Np" uniqKey="Ferenz N">NP Ferenz</name>
</author>
<author>
<name sortKey="Gable, A" uniqKey="Gable A">A Gable</name>
</author>
<author>
<name sortKey="Wadsworth, P" uniqKey="Wadsworth P">P Wadsworth</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Castillo, A" uniqKey="Castillo A">A Castillo</name>
</author>
<author>
<name sortKey="Justice, Mj" uniqKey="Justice M">MJ Justice</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Exertier, P" uniqKey="Exertier P">P Exertier</name>
</author>
<author>
<name sortKey="Javerzat, S" uniqKey="Javerzat S">S Javerzat</name>
</author>
<author>
<name sortKey="Wang, B" uniqKey="Wang B">B Wang</name>
</author>
<author>
<name sortKey="Franco, M" uniqKey="Franco M">M Franco</name>
</author>
<author>
<name sortKey="Herbert, J" uniqKey="Herbert J">J Herbert</name>
</author>
<author>
<name sortKey="Platonova, N" uniqKey="Platonova N">N Platonova</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Haque, Sa" uniqKey="Haque S">SA Haque</name>
</author>
<author>
<name sortKey="Hasaka, Tp" uniqKey="Hasaka T">TP Hasaka</name>
</author>
<author>
<name sortKey="Brooks, Ad" uniqKey="Brooks A">AD Brooks</name>
</author>
<author>
<name sortKey="Lobanov, Pv" uniqKey="Lobanov P">PV Lobanov</name>
</author>
<author>
<name sortKey="Baas, Pw" uniqKey="Baas P">PW Baas</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Herbert, Sp" uniqKey="Herbert S">SP Herbert</name>
</author>
<author>
<name sortKey="Stainier, Dy" uniqKey="Stainier D">DY Stainier</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Zhou, R" uniqKey="Zhou R">R Zhou</name>
</author>
<author>
<name sortKey="Niwa, S" uniqKey="Niwa S">S Niwa</name>
</author>
<author>
<name sortKey="Homma, N" uniqKey="Homma N">N Homma</name>
</author>
<author>
<name sortKey="Takei, Y" uniqKey="Takei Y">Y Takei</name>
</author>
<author>
<name sortKey="Hirokawa, N" uniqKey="Hirokawa N">N Hirokawa</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Midorikawa, R" uniqKey="Midorikawa R">R Midorikawa</name>
</author>
<author>
<name sortKey="Takei, Y" uniqKey="Takei Y">Y Takei</name>
</author>
<author>
<name sortKey="Hirokawa, N" uniqKey="Hirokawa N">N Hirokawa</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Harada, A" uniqKey="Harada A">A Harada</name>
</author>
<author>
<name sortKey="Teng, J" uniqKey="Teng J">J Teng</name>
</author>
<author>
<name sortKey="Takei, Y" uniqKey="Takei Y">Y Takei</name>
</author>
<author>
<name sortKey="Oguchi, K" uniqKey="Oguchi K">K Oguchi</name>
</author>
<author>
<name sortKey="Hirokawa, N" uniqKey="Hirokawa N">N Hirokawa</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Bartoli, Km" uniqKey="Bartoli K">KM Bartoli</name>
</author>
<author>
<name sortKey="Jakovljevic, J" uniqKey="Jakovljevic J">J Jakovljevic</name>
</author>
<author>
<name sortKey="Woolford, Jl" uniqKey="Woolford J">JL Woolford</name>
</author>
<author>
<name sortKey="Saunders, Ws" uniqKey="Saunders W">WS Saunders</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Ivanov, Ki" uniqKey="Ivanov K">KI Ivanov</name>
</author>
<author>
<name sortKey="Agalarov, Y" uniqKey="Agalarov Y">Y Agalarov</name>
</author>
<author>
<name sortKey="Valmu, L" uniqKey="Valmu L">L Valmu</name>
</author>
<author>
<name sortKey="Samuilova, O" uniqKey="Samuilova O">O Samuilova</name>
</author>
<author>
<name sortKey="Liebl, J" uniqKey="Liebl J">J Liebl</name>
</author>
<author>
<name sortKey="Houhou, N" uniqKey="Houhou N">N Houhou</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Brice, G" uniqKey="Brice G">G Brice</name>
</author>
<author>
<name sortKey="Mansour, S" uniqKey="Mansour S">S Mansour</name>
</author>
<author>
<name sortKey="Bell, R" uniqKey="Bell R">R Bell</name>
</author>
<author>
<name sortKey="Collin, Jr" uniqKey="Collin J">JR Collin</name>
</author>
<author>
<name sortKey="Child, Ah" uniqKey="Child A">AH Child</name>
</author>
<author>
<name sortKey="Brady, Af" uniqKey="Brady A">AF Brady</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Brice, G" uniqKey="Brice G">G Brice</name>
</author>
<author>
<name sortKey="Child, Ah" uniqKey="Child A">AH Child</name>
</author>
<author>
<name sortKey="Evans, A" uniqKey="Evans A">A Evans</name>
</author>
<author>
<name sortKey="Bell, R" uniqKey="Bell R">R Bell</name>
</author>
<author>
<name sortKey="Mansour, S" uniqKey="Mansour S">S Mansour</name>
</author>
<author>
<name sortKey="Burnand, K" uniqKey="Burnand K">K Burnand</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="research-article">
<pmc-dir>properties open_access</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Orphanet J Rare Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">Orphanet J Rare Dis</journal-id>
<journal-title-group>
<journal-title>Orphanet Journal of Rare Diseases</journal-title>
</journal-title-group>
<issn pub-type="epub">1750-1172</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">25934493</article-id>
<article-id pub-id-type="pmc">4464120</article-id>
<article-id pub-id-type="publisher-id">271</article-id>
<article-id pub-id-type="doi">10.1186/s13023-015-0271-4</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>No evidence of locus heterogeneity in familial microcephaly with or without chorioretinopathy, lymphedema, or mental retardation syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Schlögel</surname>
<given-names>Matthieu J</given-names>
</name>
<address>
<email>matthieu.schlogel@uclouvain.be</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mendola</surname>
<given-names>Antonella</given-names>
</name>
<address>
<email>antonella.mendola@uclouvain.be</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fastré</surname>
<given-names>Elodie</given-names>
</name>
<address>
<email>elodie.fastre@uclouvain.be</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vasudevan</surname>
<given-names>Pradeep</given-names>
</name>
<address>
<email>pradeep.vasudevan@uhl-tr.nhs.uk</email>
</address>
<xref ref-type="aff" rid="Aff2"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Devriendt</surname>
<given-names>Koen</given-names>
</name>
<address>
<email>koenraad.devriendt@uzleuven.be</email>
</address>
<xref ref-type="aff" rid="Aff3"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Ravel</surname>
<given-names>Thomy JL</given-names>
</name>
<address>
<email>thomy.deravel@uzleuven.be</email>
</address>
<xref ref-type="aff" rid="Aff3"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Van Esch</surname>
<given-names>Hilde</given-names>
</name>
<address>
<email>Hilde.Vanesch@uzleuven.be</email>
</address>
<xref ref-type="aff" rid="Aff3"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Casteels</surname>
<given-names>Ingele</given-names>
</name>
<address>
<email>ingele.casteels@uzleuven.be</email>
</address>
<xref ref-type="aff" rid="Aff4"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Arroyo Carrera</surname>
<given-names>Ignacio</given-names>
</name>
<address>
<email>IARROY@telefonica.net</email>
</address>
<xref ref-type="aff" rid="Aff5"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cristofoli</surname>
<given-names>Francesca</given-names>
</name>
<address>
<email>francesca.cristofoli@med.kuleuven.be</email>
</address>
<xref ref-type="aff" rid="Aff3"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fieggen</surname>
<given-names>Karen</given-names>
</name>
<address>
<email>Karen.Fieggen@uct.ac.za</email>
</address>
<xref ref-type="aff" rid="Aff6"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jones</surname>
<given-names>Katheryn</given-names>
</name>
<address>
<email>Katheryn.Jones@kp.org</email>
</address>
<xref ref-type="aff" rid="Aff7"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lipson</surname>
<given-names>Mark</given-names>
</name>
<address>
<email>Mark.Lipson@kp.org</email>
</address>
<xref ref-type="aff" rid="Aff7"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Balikova</surname>
<given-names>Irina</given-names>
</name>
<address>
<email>Irina.Balikova@ulb.ac.be</email>
</address>
<xref ref-type="aff" rid="Aff8"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Singer</surname>
<given-names>Ami</given-names>
</name>
<address>
<email>amihood@netvision.net.il</email>
</address>
<xref ref-type="aff" rid="Aff9"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Soller</surname>
<given-names>Maria</given-names>
</name>
<address>
<email>maria.soller@med.lu.se</email>
</address>
<xref ref-type="aff" rid="Aff10"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mercedes Villanueva</surname>
<given-names>María</given-names>
</name>
<address>
<email>mervi3178@yahoo.com.ar</email>
</address>
<xref ref-type="aff" rid="Aff11"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Revencu</surname>
<given-names>Nicole</given-names>
</name>
<address>
<email>nicole.revencu@uclouvain.be</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
<xref ref-type="aff" rid="Aff12"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boon</surname>
<given-names>Laurence M</given-names>
</name>
<address>
<email>laurence.boon@uclouvain.be</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
<xref ref-type="aff" rid="Aff13"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brouillard</surname>
<given-names>Pascal</given-names>
</name>
<address>
<email>pascal.brouillard@uclouvain.be</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Vikkula</surname>
<given-names>Miikka</given-names>
</name>
<address>
<email>miikka.vikkula@uclouvain.be</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
<xref ref-type="aff" rid="Aff13"></xref>
<xref ref-type="aff" rid="Aff14"></xref>
</contrib>
<aff id="Aff1">
<label></label>
Laboratory of Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Avenue Hippocrate 74, bte B1.74.06, B-1200 Brussels, Belgium</aff>
<aff id="Aff2">
<label></label>
Department of Clinical Genetics, University Hospitals of Leicester, Leicester Royal Infirmary, Leicester, LE1 5WW UK</aff>
<aff id="Aff3">
<label></label>
Center for Human Genetics, University Hospitals Leuven, KU Leuven, 3000 Leuven, Belgium</aff>
<aff id="Aff4">
<label></label>
Department of Ophthalmology, St Rafael University Hospitals, 3000 Leuven, Belgium</aff>
<aff id="Aff5">
<label></label>
Servicio de Pediatría, Hospital San Pedro de Alcántara, Cáceres, Spain</aff>
<aff id="Aff6">
<label></label>
Division of Human Genetics, University of Cape Town, 7700 Cape Town, South Africa</aff>
<aff id="Aff7">
<label></label>
Medical Genetics, Kaiser Permanente, Sacramento, CA 95815 USA</aff>
<aff id="Aff8">
<label></label>
Department of Ophthalmology, Queen Fabiola Children’s University Hospital (HUDERF), 1020 Brussels, Belgium</aff>
<aff id="Aff9">
<label></label>
Pediatrics and Medical Genetics, Barzilai Medical Center, 78306 Ashkelon, Israel</aff>
<aff id="Aff10">
<label></label>
Department of Clinical Genetics, Lund University Hospital, 221 85 Lund, Sweden</aff>
<aff id="Aff11">
<label></label>
General Hospital of Florencio Varela, Children’s Hospital Dr. Pedro Elizalde and Foundation for Neurological Diseases of Childhood (FLENI), C1270AAN Buenos Aires, Capital Federal Argentina</aff>
<aff id="Aff12">
<label></label>
Center for Human Genetics, Cliniques universitaires Saint-Luc, Université catholique de Louvain, 1200 Brussels, Belgium</aff>
<aff id="Aff13">
<label></label>
Center for Vascular Anomalies, Cliniques universitaires Saint-Luc, Université catholique de Louvain, 1200 Brussels, Belgium</aff>
<aff id="Aff14">
<label></label>
Walloon Excellence in Lifesciences and Biotechnology (WELBIO), Université catholique de Louvain, 1200 Brussels, Belgium</aff>
</contrib-group>
<pub-date pub-type="epub">
<day>2</day>
<month>5</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>2</day>
<month>5</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<volume>10</volume>
<elocation-id>52</elocation-id>
<history>
<date date-type="received">
<day>6</day>
<month>1</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>4</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>© Schlögel et al. 2015</copyright-statement>
<license license-type="open-access">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>
), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>
) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p>Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation syndrome (MCLMR) is a rare autosomal dominant disorder with variable expressivity. It is characterized by mild-to-severe microcephaly, often associated with intellectual disability, ocular defects and lymphedema. It can be sporadic or inherited. Eighty-seven patients have been described to carry a mutation in
<italic>KIF11</italic>
, which encodes a homotetrameric motor kinesin, EG5.</p>
</sec>
<sec>
<title>Methods</title>
<p>We tested 23 unreported MCLMR index patients for
<italic>KIF11</italic>
. We also reviewed the clinical phenotypes of all our patients as well as of those described in previously published studies.</p>
</sec>
<sec>
<title>Results</title>
<p>We identified 14 mutations, 12 of which are novel. We detected mutations in 12 affected individuals, from 6 out of 6 familial cases, and in 8 out of 17 sporadic patients. Phenotypic evaluation of patients (our 26 + 61 earlier published = 87) revealed microcephaly in 91%, eye anomalies in 72%, intellectual disability in 67% and lymphedema in 47% of the patients. Unaffected carriers were rare (4 out of 87: 5%). Family history is not a requisite for diagnosis; 31% (16 out of 52) were
<italic>de novo</italic>
cases.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>All inherited cases, and 50% of sporadic cases of MCLMR are due to germline
<italic>KIF11</italic>
mutations. It is possible that mosaic
<italic>KIF11</italic>
mutations cause the remainder of sporadic cases, which the methods employed here were not designed to detect. On the other hand, some of them might have another mimicking disorder and genetic defect, as microcephaly is highly heterogeneous. In aggregate,
<italic>KIF11</italic>
mutations likely cause the majority, if not all, of MCLMR.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>CDMMR</kwd>
<kwd>EG5</kwd>
<kwd>FEVR</kwd>
<kwd>Gene</kwd>
<kwd>Intellectual disability</kwd>
<kwd>KIF11</kwd>
<kwd>MCLMR</kwd>
<kwd>MLCRD</kwd>
<kwd>Mutation</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2015</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Background</title>
<p>Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation syndrome (MCLMR, OMIM 152950, ORPHA2526) can occur as a sporadic or inherited (autosomal dominant) disease [
<xref ref-type="bibr" rid="CR1">1</xref>
]. MCLMR is characterized by a broad nose, upslanting palpebral fissures, a rounded nasal tip, a long philtrum, a pointed chin, a thin upper lip, prominent ears, atrial septal defect and lymphedema of the dorsum of the feet (pedal œdema) (Figure 
<xref rid="Fig1" ref-type="fig">1</xref>
) [
<xref ref-type="bibr" rid="CR2">2</xref>
,
<xref ref-type="bibr" rid="CR3">3</xref>
]. Ocular anomalies, the most common of which is chorioretinal dysplasia, require long-term ophthalmic follow-up due to slow development. Cerebral magnetic resonance imaging may reveal a smaller, but usually structurally normal brain [
<xref ref-type="bibr" rid="CR4">4</xref>
,
<xref ref-type="bibr" rid="CR5">5</xref>
].
<fig id="Fig1">
<label>Figure 1</label>
<caption>
<p>Clinical characteristics of patients. Clinical features of MCMLR (patients I-10
<bold>(A)</bold>
, IX-10
<bold>(B)</bold>
, X-10
<bold>(C)</bold>
and XIV-10
<bold>(D)</bold>
. Note, broad nose
<bold>(A, B)</bold>
, long philtrum
<bold>(A, B)</bold>
, thin upper lip
<bold>(A, D)</bold>
, prominent ears
<bold>(C, D)</bold>
and bilateral pedal lymphedema
<bold>(A, B D)</bold>
.</p>
</caption>
<graphic xlink:href="13023_2015_271_Fig1_HTML" id="MO1"></graphic>
</fig>
</p>
<p>Historically, MCLMR syndrome was divided into two distinct entities: microcephaly, lymphedema and chorioretinal dysplasia syndrome (MLCRD), and chorioretinal dysplasia, microcephaly and mental retardation syndrome (CDMMR). The discovery of
<italic>KIF11</italic>
mutations in patients with MLCRD or CDMMR demonstrated that the phenotypes are part of a single entity with variable penetrance and expressivity [
<xref ref-type="bibr" rid="CR6">6</xref>
].
<italic>KIF11</italic>
mutations were also discovered in 5 families with familial exudative vitreoretinopathy syndrome (FEVR), which thus belongs to the phenotypic spectrum caused by
<italic>KIF11</italic>
mutations [
<xref ref-type="bibr" rid="CR7">7</xref>
]. Thirty-one different
<italic>KIF11</italic>
mutations have been described [
<xref ref-type="bibr" rid="CR6">6</xref>
-
<xref ref-type="bibr" rid="CR10">10</xref>
]. They include missense, nonsense, frameshift and splice-site mutations distributed across the gene, and are thought to cause loss-of-function. No genotype-phenotype correlation has been described. All of the mutations are autosomal-dominant or
<italic>de novo</italic>
; no autosomal recessive case with a
<italic>KIF11</italic>
mutation has been described.</p>
<p>
<italic>KIF11</italic>
is located on
<italic>10q23.33</italic>
(
<ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org">http://www.ensembl.org</ext-link>
) and encodes the kinesin family member 11 (also known as EG5, KNSL1 or TRIP5). EG5 is a 1056-amino-acid protein, which forms homotetrameric kinesin motor complexes. The N-terminal part composes the motor domain (Gly16 – Phe363), containing a microtubule-binding domain that allows sliding along microtubules, an ATP-binding site with ATPase activity (between residues Gly105 and Thr112), and three internal domains that form coiled-coil structures responsible for multimerization into homotetramers (Figure 
<xref rid="Fig2" ref-type="fig">2</xref>
). The C-terminal BimC domain also plays a role in multimerization [
<xref ref-type="bibr" rid="CR11">11</xref>
].
<fig id="Fig2">
<label>Figure 2</label>
<caption>
<p>Schematic representation of EG5 (1056 amino acids) with position of mutations causing MCLMR syndrome. Functional domains (colored),
<italic>in vitro</italic>
mutagenized residues (signs) and post-translationally modified amino acids (signs). Mutations found in this study, top; those published earlier, below (Ostergaard
<italic>et al</italic>
. 2012, Hazan
<italic>et al</italic>
. 2012, Jones
<italic>et al</italic>
. 2013, Mirzaa
<italic>et al</italic>
. 2014 and Robitaille
<italic>et al</italic>
. 2014). Splice-site alterations (¶: family II and family V) shown to result in r.211_308del; p.Thr71Argfs*8 and r.789_790insAG; p.Val264Argfs*26, respectively (Figure 
<xref rid="Fig4" ref-type="fig">4</xref>
). N.B. positions based on amino acids in Mirzaa
<italic>et al</italic>
.</p>
</caption>
<graphic xlink:href="13023_2015_271_Fig2_HTML" id="MO2"></graphic>
</fig>
</p>
<p>The aim of this study was to screen
<italic>KIF11</italic>
in a large cohort of patients with signs of MCLMR in order to identify novel mutations, assess for locus heterogeneity and genotype-phenotype correlations, and better define the clinical phenotype associated with
<italic>KIF11</italic>
mutations. Both sporadic and familial index patients were included, as well as additional family members when available
<italic>.</italic>
</p>
</sec>
<sec id="Sec2" sec-type="methods">
<title>Methods</title>
<sec id="Sec3">
<title>Patient recruitment</title>
<p>DNA extracted from blood-samples of patients was collected from different countries (Argentina, Australia, Belgium, Israel, United-Kingdom, Spain and Sweden). Informed consent was obtained for all participants, as approved by the ethical committee of the Medical Faculty at the Université catholique de Louvain, Brussels, Belgium and the respective local committees. DNA was extracted using Wizard genomic DNA purification kit (Promega). Patients V-100, XI-100 and XIII-10 have previously been described in case reports [
<xref ref-type="bibr" rid="CR12">12</xref>
-
<xref ref-type="bibr" rid="CR14">14</xref>
]. Data on certain phenotypic characteristics, including level of intellectual disability, were not standardized; evaluation by the referring clinician was used. The average age of our patients at the time of conducting the study was 21 years.</p>
</sec>
<sec id="Sec4">
<title>Sanger sequencing of
<italic>KIF11</italic>
</title>
<p>To screen for
<italic>KIF11</italic>
mutations, the 22 exons and their corresponding splice-sites were amplified, as described [
<xref ref-type="bibr" rid="CR6">6</xref>
]. Purity and size of amplicons were evaluated by agarose gel electrophoresis using GeneRuler™ 100 bp (Thermo Scientific) DNA size ladder. Direct sequencing was performed on a 3130xl Genetic Analyzer (Life Technologies). All sequences were analyzed with CLC Main Workbench 6
<sup>©</sup>
(CLC Bio), using reference sequence NG_032580.</p>
</sec>
<sec id="Sec5">
<title>Mutation analysis</title>
<p>Mutations were named according to the guidelines of the Human Genome Variation Society (
<ext-link ext-link-type="uri" xlink:href="http://www.hgvs.org/mutnomen/">http://www.hgvs.org/mutnomen/</ext-link>
), verified using Mutalyzer (
<ext-link ext-link-type="uri" xlink:href="https://mutalyzer.nl/">https://mutalyzer.nl/</ext-link>
) [
<xref ref-type="bibr" rid="CR15">15</xref>
]. The mutations have been submitted to the Vascular Anomaly and Lymphedema Mutation Database (
<ext-link ext-link-type="uri" xlink:href="http://www.icp.ucl.ac.be/vikkula/VAdb">www.icp.ucl.ac.be/vikkula/VAdb</ext-link>
). The dbSNP137 (
<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/projects/SNP/">http://www.ncbi.nlm.nih.gov/projects/SNP/</ext-link>
) [
<xref ref-type="bibr" rid="CR16">16</xref>
], 1000Genomes (
<ext-link ext-link-type="uri" xlink:href="http://browser.1000genomes.org">http://browser.1000genomes.org</ext-link>
), ESP6500 (
<ext-link ext-link-type="uri" xlink:href="http://evs.gs.washington.edu/EVS/">http://evs.gs.washington.edu/EVS/</ext-link>
), and GoNL databases (
<ext-link ext-link-type="uri" xlink:href="http://www.nlgenome.nl">http://www.nlgenome.nl</ext-link>
) of genomic variants were searched for each mutation identified, in order to eliminate any polymorphisms. The effects of amino acid changes on protein function were predicted using PolyPhen-2 (
<ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</ext-link>
) [
<xref ref-type="bibr" rid="CR17">17</xref>
] and SIFT (
<ext-link ext-link-type="uri" xlink:href="http://sift.jcvi.org/www/SIFT_enst_submit.html">http://sift.jcvi.org/www/SIFT_enst_submit.html</ext-link>
) [
<xref ref-type="bibr" rid="CR18">18</xref>
]. MutationTaster (
<ext-link ext-link-type="uri" xlink:href="http://www.mutationtaster.org/">http://www.mutationtaster.org/</ext-link>
) [
<xref ref-type="bibr" rid="CR19">19</xref>
] was used to detect potential splice-site changes. When DNA from additional family members was available, co-segregation of mutation with disease was assessed. If the mutation was not identified in either parent, the Powerplex HS16 genotyping kit (Promega) on a 3130xl Genetic Analyzer (Life Technologies) was used to confirm paternity and maternity.</p>
</sec>
<sec id="Sec6">
<title>Evaluation of splicing abnormalities associated with intronic mutations</title>
<p>RNA was extracted from EBV-transformed lymphoblasts or lymphocytes with TriPure (Roche) (patients II-10 and V-12 and 2 controls) and retro-transcribed using RevertAid H Minus First Strand cDNA Synthesis Kit (Fermentas) with random hexamers. For patient II-10 and a control, PCR-amplification was performed using primers 5’-GAGGATTGGCTGACAAGAGC and 5’-CGTGGAATTATACCAGCCAAG. After agarose gel electrophoresis, bands were extracted using QIAquick® Gel Extraction Kit (QIAGEN) and purified amplicons were sequenced and compared to the reference sequence NM_004523.3. For patient V-12 and controls, amplicons were generated with 5’-GGTTTAGAAGAAATTACAGTACAC and 5’-TGACCCTTCCCAAAGTCAAC. They were cloned into the pCR-II TOPO vector (Invitrogen) according to the manufacturer’s protocol and the plasmids were transfected into JM109 competent bacteria (Promega, Madison, WI, USA) by heat shock. For each cDNA (patient and control), 16 clones were picked and inserts were PCR-amplified and sequenced using the same primers (above).</p>
</sec>
</sec>
<sec id="Sec7" sec-type="results">
<title>Results</title>
<p>Sequencing of the 22 coding exons of
<italic>KIF11</italic>
and their flanking splice-sites identified fourteen heterozygous mutations in the 23 index patients (Table 
<xref rid="Tab1" ref-type="table">1</xref>
and Figure 
<xref rid="Fig2" ref-type="fig">2</xref>
). All patients with family history (n = 6) had a mutation. These germline variants included two nucleotide substitutions and one single nucleotide deletion; all result in premature stop codons. Three splice-site alterations were also identified. The changes co-segregated with phenotype in the five families for which we had additional samples (n = 20) (Table 
<xref rid="Tab1" ref-type="table">1</xref>
and Figure 
<xref rid="Fig3" ref-type="fig">3</xref>
).
<table-wrap id="Tab1">
<label>Table 1</label>
<caption>
<p>
<bold>Clinical features of MCLMR patients presented in order of mutation position in</bold>
<bold>
<italic>KIF11</italic>
</bold>
</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr valign="top">
<th>
<bold>Patient</bold>
</th>
<th>
<bold>Reference</bold>
</th>
<th>
<bold>Nucleotide variant NM_004523.3</bold>
</th>
<th>
<bold>Exon</bold>
</th>
<th>
<bold>Protein alteration</bold>
</th>
<th>
<bold>Inheritance</bold>
</th>
<th>
<bold>Microcephaly (SD)</bold>
</th>
<th>
<bold>Eye changes</bold>
</th>
<th>
<bold>Lymphedema</bold>
</th>
<th>
<bold>Intellectual disability</bold>
</th>
<th>
<bold>Additional clinical features</bold>
</th>
<th>
<bold>Phenotype or the same mutation described in</bold>
</th>
</tr>
</thead>
<tbody>
<tr valign="top">
<td colspan="12">
<bold>Patients with mutation</bold>
</td>
</tr>
<tr valign="top">
<td>I-10</td>
<td>LE-401-10</td>
<td>
<italic>c.245A>T</italic>
</td>
<td>3</td>
<td>p.(Tyr82Phe)</td>
<td>
<italic>de novo</italic>
</td>
<td>−7.0</td>
<td>Chorioretinitis</td>
<td>Feet</td>
<td>Severe</td>
<td>Severe sensorineural hearing loss, proteinuria, upslanting palpebral fissures, broad nose with rounded tip, anteverted nares, long philtrum with thin upper lip and pointed chin</td>
<td>-</td>
</tr>
<tr valign="top">
<td>II-2</td>
<td>LE-09-2</td>
<td>
<italic>c.308+1G>T</italic>
</td>
<td>3</td>
<td>p.(Thr71Argfs*8)</td>
<td>AD</td>
<td>−4.0</td>
<td>Normal electroretinography but discrete narrowing of blood vessels</td>
<td>-</td>
<td>-</td>
<td>-</td>
<td>-</td>
</tr>
<tr valign="top">
<td>II-10</td>
<td>LE-09-10</td>
<td>
<italic>c.308+1G>T</italic>
</td>
<td>3</td>
<td>p.(Thr71Argfs*8)
<sup>
<italic></italic>
</sup>
</td>
<td>AD</td>
<td>−3.0</td>
<td>Retinal dystrophy</td>
<td>Mild</td>
<td>Moderate</td>
<td>Scoliosis</td>
<td>-</td>
</tr>
<tr valign="top">
<td>III-10</td>
<td>LE-448-10</td>
<td>
<italic>c.436A>T</italic>
</td>
<td>5</td>
<td>p.(Lys146*)</td>
<td>AD</td>
<td>−4.4</td>
<td>Bilateral persistent hyperplastic primary vitreous, bilateral retinal detachment, bilateral glaucoma and inoperable retinal detachment right eye</td>
<td>Feet</td>
<td>-</td>
<td>Lensectomy, vitrectomy right eye and long philtrum</td>
<td>-</td>
</tr>
<tr valign="top">
<td>IV-1</td>
<td>LE-152-1</td>
<td>
<italic>c.630del</italic>
</td>
<td>6</td>
<td>p.(Tyr211Ilefs*4)</td>
<td>AD</td>
<td>−2.5</td>
<td>-</td>
<td>+</td>
<td>-</td>
<td>-</td>
<td>-</td>
</tr>
<tr valign="top">
<td>IV-10</td>
<td>LE-152-10</td>
<td>
<italic>c.630del</italic>
</td>
<td>6</td>
<td>p.(Tyr211Ilefs*4)</td>
<td>AD</td>
<td>−5.9</td>
<td>Retinal dystrophy</td>
<td>Mild</td>
<td>Moderate</td>
<td>Facial dysmorphism</td>
<td>-</td>
</tr>
<tr valign="top">
<td>IV-11</td>
<td>LE-152-11</td>
<td>
<italic>c.630del</italic>
</td>
<td>6</td>
<td>p.(Tyr211Ilefs*4)</td>
<td>AD</td>
<td>−5.9</td>
<td>Unknown, wears glasses</td>
<td>-</td>
<td>Moderate</td>
<td>Facial dysmorphism</td>
<td>-</td>
</tr>
<tr valign="top">
<td>V-1</td>
<td>LE-114-1</td>
<td>
<italic>c.790-3A>G</italic>
</td>
<td>8</td>
<td>p.(Val264Argfs*26)</td>
<td>AD</td>
<td>Within normal limits</td>
<td>-</td>
<td>-</td>
<td>-</td>
<td>-</td>
<td>-</td>
</tr>
<tr valign="top">
<td>V-11</td>
<td>LE-114-11</td>
<td>
<italic>c.790-3A>G</italic>
</td>
<td>8</td>
<td>p.(Val264Argfs*26)</td>
<td>AD</td>
<td>−2.2</td>
<td>Microphthalmos</td>
<td>-</td>
<td>-</td>
<td>-</td>
<td>-</td>
</tr>
<tr valign="top">
<td>V-12</td>
<td>LE-114-12</td>
<td>
<italic>c.790-3A>G</italic>
</td>
<td>8</td>
<td>p.(Val264Argfs*26)
<sup>
<italic></italic>
</sup>
</td>
<td>AD</td>
<td>−2.9</td>
<td>Bilateral falciform retinal folds, microphthalmos, visual deficit and glaucoma</td>
<td>Feet as a child</td>
<td>Moderate</td>
<td>Sloping forehead</td>
<td>Young ID.,
<italic>et al.</italic>
, 1987</td>
</tr>
<tr valign="top">
<td>V-100</td>
<td>LE-114-100</td>
<td>
<italic>c.790-3A>G</italic>
</td>
<td>8</td>
<td>p.(Val264Argfs*26)</td>
<td>AD</td>
<td>−6.6</td>
<td>Falciform retinal folds</td>
<td>Hands and feet</td>
<td>Moderate</td>
<td>Clinodactyly and facial dysmorphism</td>
<td>-</td>
</tr>
<tr valign="top">
<td>V-101</td>
<td>LE-114-101</td>
<td>
<italic>c.790-3A>G</italic>
</td>
<td>8</td>
<td>p.(Val264Argfs*26)</td>
<td>AD</td>
<td>−2.3</td>
<td>-</td>
<td>-</td>
<td>Mild</td>
<td>Left Club foot and dyslexia</td>
<td>-</td>
</tr>
<tr valign="top">
<td>VI-10</td>
<td>LE-103-10</td>
<td>
<italic>c.1985T>A</italic>
</td>
<td>15</td>
<td>p.(Leu662*)</td>
<td>AD</td>
<td>−5.0</td>
<td>Bilateral retinal degeneration</td>
<td>Feet</td>
<td>Mild</td>
<td>-</td>
<td>-</td>
</tr>
<tr valign="top">
<td>VI-2</td>
<td>LE-103-2</td>
<td>
<italic>c.1985T>A</italic>
</td>
<td>15</td>
<td>p.(Leu662*)</td>
<td>AD</td>
<td>-</td>
<td>-</td>
<td>Mild</td>
<td>Mild</td>
<td>-</td>
<td>-</td>
</tr>
<tr valign="top">
<td>VII-10</td>
<td>LE-411-10</td>
<td>
<italic>c.2005del</italic>
</td>
<td>16</td>
<td>p.(Glu669Lysfs*7)</td>
<td>
<italic>de novo</italic>
</td>
<td>−3v8</td>
<td>Retinal dystrophy</td>
<td>-</td>
<td>Moderate</td>
<td>Pachygyria</td>
<td>-</td>
</tr>
<tr valign="top">
<td>VIII-10</td>
<td>LE-125-10</td>
<td>
<italic>c.2160+1G>A</italic>
</td>
<td>16</td>
<td>Altered Splicing</td>
<td>
<italic>de novo</italic>
</td>
<td>−9.2</td>
<td>+</td>
<td>+</td>
<td>Moderate</td>
<td>Constipation and facial dysmorphism</td>
<td>-</td>
</tr>
<tr valign="top">
<td>IX-10</td>
<td>LE-406-10</td>
<td>
<italic>c.2244_2247dup</italic>
</td>
<td>17</td>
<td>p.(Val750*)</td>
<td>Sporadic</td>
<td>−3.0</td>
<td>Persistent hyperplastic primary vitreous posterior and retinal atrophy</td>
<td>Feet</td>
<td>Moderate</td>
<td>Facial dysmorphism</td>
<td>-</td>
</tr>
<tr valign="top">
<td>X-10</td>
<td>LE-413-10</td>
<td>
<italic>c.2304_2305del</italic>
</td>
<td>18</td>
<td>p.(His768Glnfs*7)</td>
<td>
<italic>de novo</italic>
</td>
<td>−5.4</td>
<td>Retinal dystrophy</td>
<td>-</td>
<td>Severe</td>
<td>-</td>
<td>Ostergaard P.,
<italic>et a</italic>
l., 2012</td>
</tr>
<tr valign="top">
<td>XI-10</td>
<td>LE-08-10</td>
<td>
<italic>c.2547+2T>C</italic>
</td>
<td>18</td>
<td>Altered Splicing</td>
<td>AD</td>
<td>−7.3</td>
<td>Subtle atrophic pigment epithelial changes temporally from the optic disc on the right eye and atrophic changes prominent on the left eye</td>
<td>-</td>
<td>Moderate</td>
<td>-</td>
<td>Ostergaard P.,
<italic>et a</italic>
l., 2012</td>
</tr>
<tr valign="top">
<td>XI-13</td>
<td>LE-08-13</td>
<td>
<italic>c.2547+2T>C</italic>
</td>
<td>18</td>
<td>Altered Splicing</td>
<td>AD</td>
<td>−4.4</td>
<td>Unknown</td>
<td>-</td>
<td>Moderate</td>
<td>Nasal speech and micrognathia</td>
<td>Ostergaard P.,
<italic>et a</italic>
l., 2012</td>
</tr>
<tr valign="top">
<td>XI-100</td>
<td>LE-08-100</td>
<td>
<italic>c.2547+2T>C</italic>
</td>
<td>18</td>
<td>Altered Splicing</td>
<td>AD</td>
<td>−8.3</td>
<td>Microphthalmia, chorioretinopathy and retinal dystrophy</td>
<td>Feet</td>
<td>Moderate</td>
<td>Syndactyly, cardiopathy, pachygyria and facial dysmorphism</td>
<td>Casteels I.,
<italic>et al</italic>
., 2001, Ostergaard P.,
<italic>et al</italic>
., 2012</td>
</tr>
<tr valign="top">
<td>XI-101</td>
<td>LE-08-101</td>
<td>
<italic>c.2547+2T>C</italic>
</td>
<td>18</td>
<td>Altered Splicing</td>
<td>AD</td>
<td>−4.5</td>
<td>Bilateral corioretinal dystrophy</td>
<td>+</td>
<td>Moderate</td>
<td>-</td>
<td>Ostergaard P.,
<italic>et a</italic>
l., 2012</td>
</tr>
<tr valign="top">
<td>XI-102</td>
<td>LE-08-102</td>
<td>
<italic>c.2547+2T>C</italic>
</td>
<td>18</td>
<td>Altered Splicing</td>
<td>AD</td>
<td>−3.5</td>
<td>-</td>
<td>Peri-oral</td>
<td>Moderate</td>
<td>Micrognathia, full nose tip, diathema of teeth and dysplastic ears</td>
<td>Ostergaard P.,
<italic>et a</italic>
l., 2012</td>
</tr>
<tr valign="top">
<td>XII-10</td>
<td>LE-414-10</td>
<td>
<italic>c.2723dup</italic>
</td>
<td>19</td>
<td>p.(Leu909Alafs*2)</td>
<td>
<italic>de novo</italic>
</td>
<td>−5.5</td>
<td>Retinal dystrophy</td>
<td>+</td>
<td>Severe</td>
<td>-</td>
<td>Fryns JP.,
<italic>et al</italic>
., 1995</td>
</tr>
<tr valign="top">
<td>XIII-10</td>
<td>LE-415-10</td>
<td>
<italic>c.2782_2783dup</italic>
</td>
<td>20</td>
<td>p.(Gln928Hisfs*13)</td>
<td>
<italic>de novo</italic>
</td>
<td>−3.8</td>
<td>Chorioretinal atrophy</td>
<td>-</td>
<td>Moderate</td>
<td>-</td>
<td>-</td>
</tr>
<tr valign="top">
<td>XIV-10</td>
<td>LE-104-10</td>
<td>
<italic>c.2922G>A</italic>
</td>
<td>20</td>
<td>Altered Splicing</td>
<td>
<italic>de novo</italic>
</td>
<td>−5.3</td>
<td>Myopic chorioretinal dysplasia</td>
<td>Hands and feet</td>
<td>-</td>
<td>Fairly broad nasal root, prominent ears and a narrow palate</td>
<td>-</td>
</tr>
<tr valign="top">
<td colspan="12">
<bold>Patients without a mutation</bold>
</td>
</tr>
<tr valign="top">
<td>XV-10</td>
<td>LE-87-10</td>
<td>No mutation</td>
<td>-</td>
<td>-</td>
<td>Sporadic</td>
<td>−6.9</td>
<td>Bulls eye maculopathy</td>
<td>Acute oedema at birth, resolved; bilateral lymphedema persisted</td>
<td>Severe</td>
<td>Hearing loss-bilateral sensorineural and facial dysmorphism</td>
<td>-</td>
</tr>
<tr valign="top">
<td>XVI-10</td>
<td>LE-88-10</td>
<td>No mutation</td>
<td>-</td>
<td>-</td>
<td>Sporadic</td>
<td>−8.1</td>
<td>Bilateral Falciform retinal folds</td>
<td>Mild, feet as a child</td>
<td>Moderate</td>
<td>Epilepsy and facial dysmorphism</td>
<td>-</td>
</tr>
<tr valign="top">
<td>XVII-10</td>
<td>LE-90-10</td>
<td>No mutation</td>
<td>-</td>
<td>-</td>
<td>Sporadic</td>
<td>−4.6</td>
<td>-</td>
<td>+</td>
<td>-</td>
<td>Lissencephaly, coronal craniosynostosis and ADHD</td>
<td>-</td>
</tr>
<tr valign="top">
<td>XVIII-10</td>
<td>LE-91-10</td>
<td>No mutation</td>
<td>-</td>
<td>-</td>
<td>Sporadic</td>
<td>−3.9</td>
<td>-</td>
<td>Feet and legs</td>
<td>Mild</td>
<td>Mild hypoplastic aortic arch, secundum atrial septal defects, mild motor delay, mild speech delay, ADHD and hyperlaxity</td>
<td>-</td>
</tr>
<tr valign="top">
<td>XIX-10</td>
<td>LE-121-10</td>
<td>No mutation</td>
<td>-</td>
<td>-</td>
<td>Sporadic</td>
<td>−3.0</td>
<td>-</td>
<td>Legs and face</td>
<td>Moderate</td>
<td>ADHD on methylphenidate treatment, hyperlaxity, bilateral Madelung deformity and egg allergy</td>
<td>-</td>
</tr>
<tr valign="top">
<td>XX-10</td>
<td>LE-393-10</td>
<td>No mutation</td>
<td>-</td>
<td>-</td>
<td>Sporadic</td>
<td>−5.0</td>
<td>Blind</td>
<td>Lower limbs</td>
<td>Severe</td>
<td>Cerebral atrophy, encephalopathy, cervicofacial lymphatic malformations, chylothorax, pleural effusion, hydrops fetalis and intestinal lymphangiectasia</td>
<td>-</td>
</tr>
<tr valign="top">
<td>XXI-10</td>
<td>LE-412-10</td>
<td>No mutation</td>
<td>-</td>
<td>-</td>
<td>Sporadic</td>
<td>−2.1</td>
<td>-</td>
<td>Feet</td>
<td>Moderate</td>
<td>Pectus excavatum, epicanthic folds and small ears</td>
<td>-</td>
</tr>
<tr valign="top">
<td>XXII-10</td>
<td>LE-417-10</td>
<td>No mutation</td>
<td>-</td>
<td>-</td>
<td>Sporadic</td>
<td>−4.4</td>
<td>Retinal dystrophy</td>
<td>-</td>
<td>Servere</td>
<td>Epilepsy</td>
<td>-</td>
</tr>
<tr valign="top">
<td>XXIII-10</td>
<td>LE-428-10</td>
<td>No mutation</td>
<td>-</td>
<td>-</td>
<td>Sporadic</td>
<td>−10.0</td>
<td>Chorioretinal dysplasia, myopia, nystagmus horizontale ODG</td>
<td>Mild</td>
<td>Severe</td>
<td>Arterial pulmonary hypertension, atrio-ventricular complete canal, motor delay, simplified gyral pattern, autistic behavior, ADHD, small for height (−4DS) and weight (−4DS), and facial dysmorphism.</td>
<td>-</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>+ = present, − = absent, AD = autosomal dominant, ¶ = mRNA tested, ADHD = Attention deficit hyperactivity disorder.</p>
</table-wrap-foot>
</table-wrap>
<fig id="Fig3">
<label>Figure 3</label>
<caption>
<p>Pedigrees and phenotypes of screened patients. Upper panel,
<italic>KIF11</italic>
mutation-positive; lower panel,
<italic>KIF11</italic>
mutation-negative. Individuals with a bar, clinically examined; those with a number, sequenced. Patients with a star have a mutation.</p>
</caption>
<graphic xlink:href="13023_2015_271_Fig3_HTML" id="MO3"></graphic>
</fig>
</p>
<p>Among the 17 sporadic patients, we found eight with a mutation in
<italic>KIF11</italic>
: one nonsense, four frameshifts and two canonical consensus splice-site changes (Table 
<xref rid="Tab1" ref-type="table">1</xref>
) that we consider pathogenic; and one missense alteration that we regarded as probably pathogenic, but requiring further functional validation (Table 
<xref rid="Tab1" ref-type="table">1</xref>
). DNA from parents was available for 7 of the 8 sporadic patients with a
<italic>KIF11</italic>
mutation. All appeared to be
<italic>de novo</italic>
changes (100%) (Figure 
<xref rid="Fig3" ref-type="fig">3</xref>
) absent in both parents, representing 41% (n = 7/17) of all our sporadic cases. In total, 30% of all the index cases studied (7/23) had
<italic>de novo KIF11</italic>
mutations.</p>
<p>The mutations detected most likely result in loss of function of
<italic>KIF11</italic>
due to nonsense-mediated mRNA decay or premature truncation of the protein (n = 13). Lymphoblast RNA from a patient with a splice-site alteration (Patient II-10:
<italic>c.308+1G>T</italic>
) showed skipping of exon 3 (r.211_308del) (Figure 
<xref rid="Fig4" ref-type="fig">4</xref>
A), leading to a change in reading frame (p.Thr71Argfs*8) (Figure 
<xref rid="Fig4" ref-type="fig">4</xref>
B). The mutant transcript was expressed at a lower level than the wild-type allele, suggesting mRNA loss by nonsense-mediated mRNA decay. In patient V-12, the splice-variant (
<italic>c.790-3A>G</italic>
) generates a new AG-acceptor site-like sequence. In lymphocytes, this led to the insertion of 2 nucleotides from the intronic splice site (r.789_790insAG) into the mRNA (Figure 
<xref rid="Fig4" ref-type="fig">4</xref>
C and D), causing a reading frame shift and appearance of a premature stop codon 26 amino acids after (p.Val264Argfs*26). We identified only 1 mutation leading to a heterozygous amino acid substitution: Tyr82Phe (Patient I-10). The substitution occurs at a highly conserved amino acid position in the kinesin motor domain from fish to human being. It is predicted to alter protein function by PolyPhen-2, SIFT and Mutation Taster 2.0. The change is absent in the 1000Genomes, ESP6500, and GoNL databases.
<fig id="Fig4">
<label>Figure 4</label>
<caption>
<p>Effect of splice site mutations.
<bold>(A)</bold>
RT-PCR using primers in exon 2 and 5 on cDNA from patient II-10 (
<italic>c.308+1G>T</italic>
) and two controls (c1 and c2). Wild-type amplicon, 250 bp; mutant, 152 bp.
<bold>(B)</bold>
(Sequencing of lower band unraveled skipping of exon 3 resulting in a premature stop-codon (r.211_308del: p.Thr71Argfs*8).
<bold>(C)</bold>
Sequencing of cDNA of patient V-12 (
<italic>c.790-3A>G</italic>
) for an amplicon covering exon 7/8 splice site revealed double-sequence.
<bold>(D)</bold>
Sequencing of cloned amplicon fragments revealed insertion of 2 nucleotides (AG) from the intronic acceptor site (r.790_791insAG) in mutant clones. This leads to a premature stop-codon (p.Val264Argfs*26).</p>
</caption>
<graphic xlink:href="13023_2015_271_Fig4_HTML" id="MO4"></graphic>
</fig>
</p>
<p>Taking into account all the patients found to carry a mutation in this study (n = 26), as well as the 61 already reported [
<xref ref-type="bibr" rid="CR6">6</xref>
-
<xref ref-type="bibr" rid="CR10">10</xref>
], microcephaly was present in 79/87 patients (91%), eye anomalies in 63/87 patients (72%), intellectual disability in 58/87 (67%) and lymphedema in 41/87 patients (47%). Average SD for microcephaly was −5,1 (ranging from −1,1 to −9,5), on the basis of 64 patients with published data. None of the clinical signs was fully penetrant. Atypical features including cerebral and cardiac anomalies were present in 48 patients (55%). Taking all index patients with mutations into account (n = 52), sporadic cases represent 42% (22/52). It has been proven in 73% (16/22) of them that the mutation appeared
<italic>de novo</italic>
.</p>
<p>The nine
<italic>KIF11</italic>
mutation-negative sporadic patients were included in
<italic>KIF11</italic>
mutation screening due to the presence of signs and symptoms corresponding to MCLMR. However, certain patients showed additional features, not described for MCLMR: hydrops fetalis and lymphangiectasia (1 patient: XX-10), motor delay (2 patients: XVIII-10, XXIII-10), and Madelung deformity (1 patient: XIX-10). These patients probably reflect the clinical and genetic variability of microcephaly syndromes.</p>
</sec>
<sec id="Sec8" sec-type="discussion">
<title>Discussion</title>
<p>We discovered 14
<italic>KIF11</italic>
mutations, 12 of which are novel, in 26 MCLMR patients (Figure 
<xref rid="Fig2" ref-type="fig">2</xref>
). A mutation was detected in all patients with a family history of MCLMR, similar to previously reported series [
<xref ref-type="bibr" rid="CR6">6</xref>
-
<xref ref-type="bibr" rid="CR10">10</xref>
]. We also discovered a heterozygous germline
<italic>de novo</italic>
mutation in 7 sporadic patients and in 1 patient without family history of MCLMR, but for whom no parental DNA was available for testing. Thus, 87,5% of our sporadic patients with a
<italic>KIF11</italic>
mutation had a proven
<italic>de novo</italic>
mutation. This represents 41% (7/17) of sporadic index patients in this study. Taking into account all index patients with a
<italic>KIF11</italic>
mutation, sixteen sporadic patients have been reported to have a
<italic>de novo</italic>
mutation (7 in the current study, and 9 in previously published works), indicating that
<italic>KIF11</italic>
has a high
<italic>de novo</italic>
mutation rate: 16
<italic>de novo</italic>
/52 mutation-positive index patients; i.e. 31% across studies. Several
<italic>de novo</italic>
mutations have also been identified in other genes mutated in microcephaly (i.e. CTNNB1 [
<xref ref-type="bibr" rid="CR20">20</xref>
] and TUBA1A [
<xref ref-type="bibr" rid="CR21">21</xref>
]) and in primary lymphedema, such as
<italic>SOX18</italic>
,
<italic>FOXC2</italic>
and
<italic>VEGFR3</italic>
[
<xref ref-type="bibr" rid="CR22">22</xref>
-
<xref ref-type="bibr" rid="CR24">24</xref>
].</p>
<p>No
<italic>KIF11</italic>
mutation-negative familial cases were identified; however, about half of the sporadic cases were
<italic>KIF11</italic>
mutation-negative. These may be explained by several hypotheses: (1) Deletions or deep-intronic mutations in
<italic>KIF11</italic>
, which were not assessed in the study; (2) Somatic/mosaic
<italic>KIF11</italic>
mutations that are not detectable in the blood by Sanger sequencing: mosaicism as a cause of MCLMR can be investigated by sequencing tissue and blood-DNA using targeted deep sequencing; (3) Existence of a mimicking disorder: many different genes can cause microcephaly, including those implicated in autosomal recessive primary microcephaly and syndromic microcephaly [
<xref ref-type="bibr" rid="CR25">25</xref>
], or primary lymphedema [
<xref ref-type="bibr" rid="CR26">26</xref>
]. The presence of motor delay in patients XVIII-10 and XIII-10 may suggest Cohen syndrome (OMIM 216550) [
<xref ref-type="bibr" rid="CR27">27</xref>
]. The Madelung deformity and hydrops fetalis observed in two other patients may also be indicative of a distinct syndrome, as they have never been described in MCLMR. Eight out of nine of our negative cases had microcephaly and lymphedema; (4) Novel genetic cause for MCLMR in mutation-negative patients. Overall, our results suggest that
<italic>KIF11</italic>
is the major causative gene for MCLMR, with no evidence of locus heterogeneity in familial cases.</p>
<p>The most frequent clinical signs and symptoms in patients with a
<italic>KIF11</italic>
mutation are microcephaly (91%), eye anomalies (72%) and intellectual disability (67%) (Figure 
<xref rid="Fig3" ref-type="fig">3</xref>
and Table 
<xref rid="Tab1" ref-type="table">1</xref>
). MCLMR patients may have a structurally abnormal brain
<italic>i.e</italic>
. pachygyria (Table 
<xref rid="Tab1" ref-type="table">1</xref>
: Patients VII-10 & XI-100) [
<xref ref-type="bibr" rid="CR9">9</xref>
]. Lymphedema is present in 47% of mutation-positive patients (Table 
<xref rid="Tab1" ref-type="table">1</xref>
).</p>
<p>Although none of the individual symptoms is fully penetrant, the overall penetrance of MCLMR is high (83/87; 95%). Only 4 asymptomatic mutation carriers have been identified amongst 87 individuals tested. Patients in the same family (Family II, IV, V, VI, and XI), with the same mutation may however have different phenotypes, demonstrating variable expressivity.</p>
<p>The 44 mutations identified so far in
<italic>KIF11</italic>
(nine missense, twenty-five premature stop codons and ten splice-site changes) are scattered across the length of gene (Figure 
<xref rid="Fig2" ref-type="fig">2</xref>
). There are no clear phenotypic differences between missense mutation carriers and those with premature stop codon mutations. As the most 5’ premature truncation codon occurs at the very 5’ end (amino acid 47), and lymphoblasts had a significantly lower expression of the mutant allele of patient II-10 (
<italic>c.308+1G>T</italic>
), all mutations most likely cause loss of
<italic>EG5</italic>
function.</p>
<p>
<italic>KIF11</italic>
mutations have pleiotropic effects with variable penetrance. One possible explanation could be the occurrence of somatic second-hit mutation(s), as we have proven for glomuvenous malformation [
<xref ref-type="bibr" rid="CR28">28</xref>
,
<xref ref-type="bibr" rid="CR29">29</xref>
] and mucocutaneous venous malformation [
<xref ref-type="bibr" rid="CR30">30</xref>
]. Random somatic changes inevitably occur in the cells of all individuals, and result in a double-hit situation in some cells in patients with a germline mutation. The resulting phenotypes would depend on the types and developmental stages of cells affected.</p>
<p>There are nine amino acid substitutions identified in MCLMR patients. One of them affects the initiating methionine at position 1 (p.Met1Thr) most likely causing non-translation of
<italic>KIF11</italic>
. Seven of the remaining eight amino acid substitutions occur in the kinesin motor domain (p.Tyr82Phe, p.Phe144Leu, p.Arg221Gly, p.Arg234Cys, p.Ser235Cys, p.His244Tyr, and p.Glu344Lys) and the last one in the BimC Box (p.Arg944Cys), implicated in multimerization (Figure 
<xref rid="Fig2" ref-type="fig">2</xref>
). Both domains have been shown to be important for
<italic>KIF11</italic>
function during mitosis [
<xref ref-type="bibr" rid="CR11">11</xref>
]. The kinesin motor domain contains amino acids important for tertiary structure. Arg234 makes a salt bridge with Glu270 to close the active site essential for ATP hydrolysis [
<xref ref-type="bibr" rid="CR31">31</xref>
]. Substitution of Arg234 for a cysteine likely perturbs closure of the pocket and ATP hydrolysis. The impact of Ser235Cys is likely similar due to its vicinity to Arg234. In addition, the serine-to-cysteine change would affect polarity and thus modify the stabilization of a molecule of water in the nucleotide-binding pocket. Moreover, in the 3D structure (PDB ID: 3hqd), Arg221 is located in front of Ser235. Substitution for glycine could influence the structure of the nucleotide-binding pocket. Tyr82, Phe144 and Glu344 are located in an alpha-helix and His244 in a central beta-sheet in the kinesin domain. It is unclear whether these mutations, and the BimC Box mutation, affect stability, structure and/or function.</p>
<p>
<italic>In vitro</italic>
mutagenesis (Pro131Ala, Thr926Ala and Ser1033Ala) showed that the N-tail and the BimC domain are important for intra-cellular localization of the protein [
<xref ref-type="bibr" rid="CR32">32</xref>
]. Thr926 of the BimC domain is phosphorylated by CDK1 (Cyclin-dependent kinase 1), whereas Ser1033 is partially phosphorylated by NEK6 (Never in mitosis gene a -related kinase 6). Phosphorylation of these sites is important for the mitotic function of EG5 [
<xref ref-type="bibr" rid="CR33">33</xref>
,
<xref ref-type="bibr" rid="CR34">34</xref>
]. Depletion of
<italic>KIF11</italic>
causes mitotic arrest. This can be rescued by re-expression of the protein, but not by a Thr926Ala mutant, which lacks the ability to interact with microtubules [
<xref ref-type="bibr" rid="CR33">33</xref>
]. The Arg944Cys mutation likely causes dysfunction of this same domain.</p>
<p>EG5 is a plus end-directed microtubule motor. It contributes to the establishment and maintenance of bipolar spindles during mitosis and meiosis that push the poles apart [
<xref ref-type="bibr" rid="CR35">35</xref>
]. This is required for the separation of duplicated centrosomes. EG5 is considered as a slow kinesin, which slows down the spindle separation during mitosis. It is dispersed in the cytoplasm during the interphase, regroups at the spindle poles during prophase and stays alongside the spindle in metaphase. In mice, Eg5 is expressed in proliferative tissues. Disruption by homozygous deletion of
<italic>Kif11</italic>
in mice resulted in embryonic lethality due to defective implantation in the uterine wall [
<xref ref-type="bibr" rid="CR36">36</xref>
]. Microcephaly, ocular anomalies and œdema were not reported in heterozygous embryos. Morpholino-based knock-down of
<italic>Kif11</italic>
also led to embryonic lethality, or severe œdema and circulation defects [
<xref ref-type="bibr" rid="CR37">37</xref>
]. Inhibition of EG5 by dimethylenastron (DMN) or ispinesib diminished endothelial cell proliferation (HUVEC, hCMEC/D3 and LEC) and embryonic angiogenesis [
<xref ref-type="bibr" rid="CR37">37</xref>
].</p>
<p>EG5 disruption is implicated in neuronal development and the phenotype observed in MCLMR adds
<italic>KIF11</italic>
to the long list of genes implicated in intellectual disability. Inhibition of EG5 in cultures of synaptic neurons led to faster growth of axons, with an abnormal maturation [
<xref ref-type="bibr" rid="CR38">38</xref>
]. Intellectual disability due to EG5 dysfunction could thus be explained by neuronal inability to grow and/or to connect correctly. The etiopathogenesis of the eye anomalies could be due to defective neurogenesis or angiogenesis.</p>
<p>EG5 could cause lymphedema by a microtubule-dependent function in trafficking the major lymphangiogenic tyrosine kinase receptor, VEGFR3, in endocytotic vesicles [
<xref ref-type="bibr" rid="CR39">39</xref>
]. On the other hand, it could be that the endothelial cell function of EG5 is independent of the kinesin-motor domain, as is the case for KIF26A (kinesin family member 26A), KIF4 (kinesin family member 4A/B) and MAP2 (microtubule-associated protein 2) [
<xref ref-type="bibr" rid="CR40">40</xref>
-
<xref ref-type="bibr" rid="CR42">42</xref>
]. In fact, EG5 plays also a role in protein translation [
<xref ref-type="bibr" rid="CR43">43</xref>
]. The expression of
<italic>KIF11</italic>
in LECs is regulated by FOXC2, a major lymphangiogenic transcription factor [
<xref ref-type="bibr" rid="CR44">44</xref>
]. It is however not known if MCLMR patients have lymphatic hyperplasia as observed in FOXC2-mutated patients (lymph and venous reflux and failure or absence of lymphatic and venous valves) or hypoplasia as seen in VEGFR3-mutation caused Nonne-Milroy lymphedema [
<xref ref-type="bibr" rid="CR45">45</xref>
,
<xref ref-type="bibr" rid="CR46">46</xref>
]. Lymphoscintigraph of one MCLMR patient showed no significant main-tract filling suggesting a peripheral lymphatic-vessel dysfunction [
<xref ref-type="bibr" rid="CR6">6</xref>
].</p>
</sec>
<sec id="Sec9" sec-type="conclusions">
<title>Conclusions</title>
<p>
<italic>KIF11</italic>
mutations are identified in all familial cases of MCLMR.
<italic>De novo</italic>
mutation rate is high for
<italic>KIF11</italic>
: 16 out of 22 (73%) sporadic cases. Mutations most likely cause loss of EG5 function. There is no genotype-phenotype correlation. The phenotype of the
<italic>KIF11</italic>
mutation-negative sporadic patients may be due to non-detected germline or mosaic
<italic>KIF11</italic>
mutations and/or defects in (a) gene(s) causing (a) mimicking disorder(s), as microcephaly and primary lymphedema are genetically highly heterogeneous. A better elucidation of the pathophysiological mechanisms is needed to enable development of targeted therapies for MCLMR.</p>
<sec id="Sec10">
<title>Availability of supporting data</title>
<p>The mutations were submitted to the Vascular Anomaly and Lymphedema Mutation Database (
<ext-link ext-link-type="uri" xlink:href="http://www.icp.ucl.ac.be/vikkula/VAdb">www.icp.ucl.ac.be/vikkula/VAdb</ext-link>
).</p>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>MCLMR</term>
<def>
<p>Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation</p>
</def>
</def-item>
<def-item>
<term>KIF11</term>
<def>
<p>Kinesin family member 11</p>
</def>
</def-item>
<def-item>
<term>CDMMR</term>
<def>
<p>Chorioretinal dysplasia, microcephaly and mental retardation syndrome</p>
</def>
</def-item>
<def-item>
<term>MLCRD</term>
<def>
<p>Microcephaly, lymphedema and chorioretinal dysplasia syndrome</p>
</def>
</def-item>
<def-item>
<term>FEVR</term>
<def>
<p>Familial exudative vitreoretinopathy syndrome</p>
</def>
</def-item>
<def-item>
<term>EBV</term>
<def>
<p>Epstein-barr virus</p>
</def>
</def-item>
<def-item>
<term>SOX18</term>
<def>
<p>SRY (sex determining region Y)-box 18</p>
</def>
</def-item>
<def-item>
<term>FOXC2</term>
<def>
<p>Forkhead box C2 (MFH-1, mesenchyme forkhead 1)</p>
</def>
</def-item>
<def-item>
<term>VEGFR3</term>
<def>
<p>Fms-related tyrosine kinase 4</p>
</def>
</def-item>
<def-item>
<term>CTNNB1</term>
<def>
<p>Catenin beta 1</p>
</def>
</def-item>
<def-item>
<term>TUBA1A</term>
<def>
<p>Tubulin alpha 1a</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Competing interests</bold>
</p>
<p>The authors declare that they have no competing interests.</p>
</fn>
<fn>
<p>
<bold>Authors’ contributions</bold>
</p>
<p>PB and MV designed the research. MJS, AM and EF carried out the molecular genetic studies. PV, KD, TJLR, HVE, IC, AC, FC, KF, KJ, ML, IB, AS, MS, MMV, NR and LMB collected medical information and blood samples. MJS, PB and MV wrote the manuscript. All authors read and approved the final manuscript.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>We are grateful to all family members for their participation. This work was supported by Belgian Science Policy Office Interuniversity Attraction Poles (BELSPO-IAP) programme through the project IAP P7/43-BeMGI; and the F.R.S.-FNRS (Fonds de la Recherche Scientifique). We also acknowledge the Fédération de Wallonie-Bruxelles and the Lotterie nationale of Belgium for their support. MJS and EF are doctoral students supported by the Fonds pour la Formation à la Recherche dans l’Industrie et dans l’Agriculture (FRIA).</p>
</ack>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKusick</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Stauffer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Knox</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>DB</given-names>
</name>
</person-group>
<article-title>Chorioretinopathy with hereditary microcephaly</article-title>
<source>Arch Ophthalmol</source>
<year>1966</year>
<volume>75</volume>
<fpage>597</fpage>
<lpage>600</lpage>
<pub-id pub-id-type="doi">10.1001/archopht.1966.00970050599003</pub-id>
<pub-id pub-id-type="pmid">5936364</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vasudevan</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Garcia-Minaur</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Botella</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Perez-Aytes</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shannon</surname>
<given-names>NL</given-names>
</name>
<name>
<surname>Quarrell</surname>
<given-names>OW</given-names>
</name>
</person-group>
<article-title>Microcephaly-lymphoedema-chorioretinal dysplasia: three cases to delineate the facial phenotype and review of the literature</article-title>
<source>Clin Dysmorphol</source>
<year>2005</year>
<volume>14</volume>
<fpage>109</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1097/00019605-200507000-00001</pub-id>
<pub-id pub-id-type="pmid">15930898</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eventov-Friedman</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Singer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shinwell</surname>
<given-names>ES</given-names>
</name>
</person-group>
<article-title>Microcephaly, lymphedema, chorioretinopathy and atrial septal defect: a case report and review of the literature</article-title>
<source>Acta Paediatr</source>
<year>2009</year>
<volume>98</volume>
<fpage>758</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1111/j.1651-2227.2008.01161.x</pub-id>
<pub-id pub-id-type="pmid">19076985</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vasudevan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Biswas</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Lloyd</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microcephaly with chorioretinal dysplasia: two case reports and a review of the literature</article-title>
<source>Ophthalmic Genet</source>
<year>2009</year>
<volume>30</volume>
<fpage>157</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.3109/13816810903147980</pub-id>
<pub-id pub-id-type="pmid">19852571</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>YS</given-names>
</name>
</person-group>
<article-title>Lissencephaly and mild cerebellar vermis hypoplasia in a case of microcephaly and chorioretinal dysplasia</article-title>
<source>Ophthalmic Genet</source>
<year>2010</year>
<volume>31</volume>
<fpage>89</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.3109/13816811003620509</pub-id>
<pub-id pub-id-type="pmid">20450312</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ostergaard</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Mendola</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vasudevan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Connell</surname>
<given-names>FC</given-names>
</name>
<name>
<surname>van Impel</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in KIF11 cause autosomal-dominant microcephaly variably associated with congenital lymphedema and chorioretinopathy</article-title>
<source>Am J Hum Genet</source>
<year>2012</year>
<volume>90</volume>
<fpage>356</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2011.12.018</pub-id>
<pub-id pub-id-type="pmid">22284827</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robitaille</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Gillett</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>LeBlanc</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Gaston</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Nightingale</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mackley</surname>
<given-names>MP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Phenotypic overlap between familial exudative vitreoretinopathy and microcephaly, lymphedema, and chorioretinal dysplasia caused by KIF11 mutations</article-title>
<source>JAMA Ophthalmol.</source>
<year>2014</year>
<volume>132</volume>
<fpage>1393</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1001/jamaophthalmol.2014.2814</pub-id>
<pub-id pub-id-type="pmid">25124931</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hazan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ostergaard</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ozturk</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kantekin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Atlihan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Jeffery</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A novel KIF11 mutation in a Turkish patient with microcephaly, lymphedema, and chorioretinal dysplasia from a consanguineous family</article-title>
<source>Am J Med Genet A.</source>
<year>2012</year>
<volume>158A</volume>
<fpage>1686</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.35371</pub-id>
<pub-id pub-id-type="pmid">22653704</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Ostergaard</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Connell</surname>
<given-names>FC</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Quarrell</surname>
<given-names>O</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microcephaly with or without chorioretinopathy, lymphoedema, or mental retardation (MCLMR): review of phenotype associated with KIF11 mutations</article-title>
<source>Eur J Hum Genet.</source>
<year>2013</year>
<volume>22</volume>
<fpage>881</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2013.263</pub-id>
<pub-id pub-id-type="pmid">24281367</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mirzaa</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Enyedi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Parsons</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Medne</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Congenital microcephaly and chorioretinopathy due to de novo heterozygous KIF11 mutations: Five novel mutations and review of the literature</article-title>
<source>Am J Med Genet A.</source>
<year>2014</year>
<volume>164A</volume>
<fpage>2879</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.36707</pub-id>
<pub-id pub-id-type="pmid">25115524</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Le Guellec</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Paris</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Couturier</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Roghi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Philippe</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Cloning by differential screening of a Xenopus cDNA that encodes a kinesin-related protein</article-title>
<source>Mol Cell Biol</source>
<year>1991</year>
<volume>11</volume>
<fpage>3395</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">1710028</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casteels</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Devriendt</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Van Cleynenbreugel</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Demaerel</surname>
<given-names>P</given-names>
</name>
<name>
<surname>De Tavernier</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Fryns</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title>Autosomal dominant microcephaly–lymphoedema-chorioretinal dysplasia syndrome</article-title>
<source>Br J Ophthalmol</source>
<year>2001</year>
<volume>85</volume>
<fpage>499</fpage>
<lpage>500</lpage>
<pub-id pub-id-type="doi">10.1136/bjo.85.4.496d</pub-id>
<pub-id pub-id-type="pmid">11302131</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>ID</given-names>
</name>
<name>
<surname>Fielder</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Microcephaly, microphthalmos, and retinal folds: report of a family</article-title>
<source>J Med Genet</source>
<year>1987</year>
<volume>24</volume>
<fpage>172</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.24.3.172</pub-id>
<pub-id pub-id-type="pmid">3573001</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fryns</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Smeets</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Van den Berghe</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>On the nosology of the “primary true microcephaly, chorioretinal dysplasia, lymphoedema” association</article-title>
<source>Clin Genet</source>
<year>1995</year>
<volume>48</volume>
<fpage>131</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-0004.1995.tb04072.x</pub-id>
<pub-id pub-id-type="pmid">8556819</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wildeman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>van Ophuizen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>den Dunnen</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Taschner</surname>
<given-names>PE</given-names>
</name>
</person-group>
<article-title>Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker</article-title>
<source>Hum Mutat</source>
<year>2008</year>
<volume>29</volume>
<fpage>6</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1002/humu.20654</pub-id>
<pub-id pub-id-type="pmid">18000842</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sherry</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Kholodov</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Phan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Smigielski</surname>
<given-names>EM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>dbSNP: the NCBI database of genetic variation</article-title>
<source>Nucleic Acids Res</source>
<year>2001</year>
<volume>29</volume>
<fpage>308</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1093/nar/29.1.308</pub-id>
<pub-id pub-id-type="pmid">11125122</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adzhubei</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Peshkin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ramensky</surname>
<given-names>VE</given-names>
</name>
<name>
<surname>Gerasimova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bork</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A method and server for predicting damaging missense mutations</article-title>
<source>Nat Methods</source>
<year>2010</year>
<volume>7</volume>
<fpage>248</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth0410-248</pub-id>
<pub-id pub-id-type="pmid">20354512</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Henikoff</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>SIFT: Predicting amino acid changes that affect protein function</article-title>
<source>Nucleic Acids Res</source>
<year>2003</year>
<volume>31</volume>
<fpage>3812</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkg509</pub-id>
<pub-id pub-id-type="pmid">12824425</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwarz</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Rodelsperger</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schuelke</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Seelow</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>MutationTaster evaluates disease-causing potential of sequence alterations</article-title>
<source>Nat Methods</source>
<year>2010</year>
<volume>7</volume>
<fpage>575</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth0810-575</pub-id>
<pub-id pub-id-type="pmid">20676075</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuechler</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Willemsen</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Albrecht</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bacino</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Bartholomew</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>van Bokhoven</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum</article-title>
<source>Hum Genet</source>
<year>2015</year>
<volume>134</volume>
<fpage>97</fpage>
<lpage>109</lpage>
<pub-id pub-id-type="doi">10.1007/s00439-014-1498-1</pub-id>
<pub-id pub-id-type="pmid">25326669</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sohal</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Montgomery</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mitra</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ramesh</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>TUBA1A mutation-associated lissencephaly: case report and review of the literature</article-title>
<source>Pediatr Neurol</source>
<year>2012</year>
<volume>46</volume>
<fpage>127</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2011.11.017</pub-id>
<pub-id pub-id-type="pmid">22264709</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brouillard</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Boon</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Vikkula</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Genetics of lymphatic anomalies</article-title>
<source>J Clin Invest</source>
<year>2014</year>
<volume>124</volume>
<fpage>898</fpage>
<lpage>904</lpage>
<pub-id pub-id-type="doi">10.1172/JCI71614</pub-id>
<pub-id pub-id-type="pmid">24590274</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghalamkarpour</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Debauche</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Haan</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Van Regemorter</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sznajer</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sporadic in utero generalized edema caused by mutations in the lymphangiogenic genes VEGFR3 and FOXC2</article-title>
<source>J Pediatr</source>
<year>2009</year>
<volume>155</volume>
<fpage>90</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpeds.2009.02.023</pub-id>
<pub-id pub-id-type="pmid">19394045</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Irrthum</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Devriendt</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chitayat</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Matthijs</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Glade</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Steijlen</surname>
<given-names>PM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia</article-title>
<source>Am J Hum Genet</source>
<year>2003</year>
<volume>72</volume>
<fpage>1470</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1086/375614</pub-id>
<pub-id pub-id-type="pmid">12740761</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>von der Hagen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pivarcsi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liebe</surname>
<given-names>J</given-names>
</name>
<name>
<surname>von Bernuth</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Didonato</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hennermann</surname>
<given-names>JB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diagnostic approach to microcephaly in childhood: a two-center study and review of the literature</article-title>
<source>Dev Med Child Neurol</source>
<year>2014</year>
<volume>56</volume>
<fpage>732</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1111/dmcn.12425</pub-id>
<pub-id pub-id-type="pmid">24617602</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Schlögel</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Brouillard</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Boon</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Vikkula</surname>
<given-names>M</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Arin</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Genetic Causes of Lymphedema</article-title>
<source>Lymphedema</source>
<year>2015</year>
<publisher-loc>Greene SAS, Håkan Brorson. Switzerland</publisher-loc>
<publisher-name>Springer International Publishing</publisher-name>
<fpage>19</fpage>
<lpage>31</lpage>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Douzgou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>MB</given-names>
</name>
</person-group>
<article-title>Clinical variability of genetic isolates of Cohen syndrome</article-title>
<source>Clin Genet</source>
<year>2011</year>
<volume>79</volume>
<fpage>501</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-0004.2011.01669.x</pub-id>
<pub-id pub-id-type="pmid">21418059</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brouillard</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Boon</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Mulliken</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Enjolras</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Ghassibe</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Warman</surname>
<given-names>ML</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations (“glomangiomas”)</article-title>
<source>Am J Hum Genet</source>
<year>2002</year>
<volume>70</volume>
<fpage>866</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1086/339492</pub-id>
<pub-id pub-id-type="pmid">11845407</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amyere</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Aerts</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Brouillard</surname>
<given-names>P</given-names>
</name>
<name>
<surname>McIntyre</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Duhoux</surname>
<given-names>FP</given-names>
</name>
<name>
<surname>Wassef</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Somatic uniparental isodisomy explains multifocality of glomuvenous malformations</article-title>
<source>Am J Hum Genet</source>
<year>2013</year>
<volume>92</volume>
<fpage>188</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2012.12.017</pub-id>
<pub-id pub-id-type="pmid">23375657</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Limaye</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wouters</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Uebelhoer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tuominen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wirkkala</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mulliken</surname>
<given-names>JB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations</article-title>
<source>Nat Genet</source>
<year>2009</year>
<volume>41</volume>
<fpage>118</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1038/ng.272</pub-id>
<pub-id pub-id-type="pmid">19079259</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parke</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Wojcik</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Worthylake</surname>
<given-names>DK</given-names>
</name>
</person-group>
<article-title>ATP hydrolysis in Eg5 kinesin involves a catalytic two-water mechanism</article-title>
<source>J Biol Chem</source>
<year>2010</year>
<volume>285</volume>
<fpage>5859</fpage>
<lpage>67</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M109.071233</pub-id>
<pub-id pub-id-type="pmid">20018897</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sawin</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Mitchison</surname>
<given-names>TJ</given-names>
</name>
</person-group>
<article-title>Mutations in the kinesin-like protein Eg5 disrupting localization to the mitotic spindle</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>1995</year>
<volume>92</volume>
<fpage>4289</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.92.10.4289</pub-id>
<pub-id pub-id-type="pmid">7753799</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rapley</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nicolas</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Groen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Regue</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bertran</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Caelles</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The NIMA-family kinase Nek6 phosphorylates the kinesin Eg5 at a novel site necessary for mitotic spindle formation</article-title>
<source>J Cell Sci</source>
<year>2008</year>
<volume>121</volume>
<fpage>3912</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1242/jcs.035360</pub-id>
<pub-id pub-id-type="pmid">19001501</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bertran</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Sdelci</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Regue</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Avruch</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Caelles</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Roig</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Nek9 is a Plk1-activated kinase that controls early centrosome separation through Nek6/7 and Eg5</article-title>
<source>Embo J</source>
<year>2011</year>
<volume>30</volume>
<fpage>2634</fpage>
<lpage>47</lpage>
<pub-id pub-id-type="doi">10.1038/emboj.2011.179</pub-id>
<pub-id pub-id-type="pmid">21642957</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferenz</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Gable</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wadsworth</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Mitotic functions of kinesin-5</article-title>
<source>Semin Cell Dev Biol</source>
<year>2010</year>
<volume>21</volume>
<fpage>255</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.semcdb.2010.01.019</pub-id>
<pub-id pub-id-type="pmid">20109572</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castillo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Justice</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>The kinesin related motor protein, Eg5, is essential for maintenance of pre-implantation embryogenesis</article-title>
<source>Biochem Biophys Res Commun</source>
<year>2007</year>
<volume>357</volume>
<fpage>694</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2007.04.021</pub-id>
<pub-id pub-id-type="pmid">17449012</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Exertier</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Javerzat</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Franco</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Herbert</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Platonova</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5</article-title>
<source>Oncotarget</source>
<year>2013</year>
<volume>4</volume>
<fpage>2302</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="pmid">24327603</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haque</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Hasaka</surname>
<given-names>TP</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Lobanov</surname>
<given-names>PV</given-names>
</name>
<name>
<surname>Baas</surname>
<given-names>PW</given-names>
</name>
</person-group>
<article-title>Monastrol, a prototype anti-cancer drug that inhibits a mitotic kinesin, induces rapid bursts of axonal outgrowth from cultured postmitotic neurons</article-title>
<source>Cell Motil Cytoskeleton</source>
<year>2004</year>
<volume>58</volume>
<fpage>10</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1002/cm.10176</pub-id>
<pub-id pub-id-type="pmid">14983520</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herbert</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Stainier</surname>
<given-names>DY</given-names>
</name>
</person-group>
<article-title>Molecular control of endothelial cell behaviour during blood vessel morphogenesis</article-title>
<source>Nat Rev Mol Cell Biol</source>
<year>2011</year>
<volume>12</volume>
<fpage>551</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1038/nrm3176</pub-id>
<pub-id pub-id-type="pmid">21860391</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Niwa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Homma</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Takei</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hirokawa</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>KIF26A is an unconventional kinesin and regulates GDNF-Ret signaling in enteric neuronal development</article-title>
<source>Cell</source>
<year>2009</year>
<volume>139</volume>
<fpage>802</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2009.10.023</pub-id>
<pub-id pub-id-type="pmid">19914172</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Midorikawa</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Takei</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hirokawa</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>KIF4 motor regulates activity-dependent neuronal survival by suppressing PARP-1 enzymatic activity</article-title>
<source>Cell</source>
<year>2006</year>
<volume>125</volume>
<fpage>371</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2006.02.039</pub-id>
<pub-id pub-id-type="pmid">16630823</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harada</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Takei</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Oguchi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hirokawa</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>MAP2 is required for dendrite elongation, PKA anchoring in dendrites, and proper PKA signal transduction</article-title>
<source>J Cell Biol</source>
<year>2002</year>
<volume>158</volume>
<fpage>541</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.200110134</pub-id>
<pub-id pub-id-type="pmid">12163474</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartoli</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Jakovljevic</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Woolford</surname>
<given-names>JL</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Saunders</surname>
<given-names>WS</given-names>
</name>
</person-group>
<article-title>Kinesin molecular motor Eg5 functions during polypeptide synthesis</article-title>
<source>Mol Biol Cell</source>
<year>2011</year>
<volume>22</volume>
<fpage>3420</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="doi">10.1091/mbc.E11-03-0211</pub-id>
<pub-id pub-id-type="pmid">21795388</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ivanov</surname>
<given-names>KI</given-names>
</name>
<name>
<surname>Agalarov</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Valmu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Samuilova</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Liebl</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Houhou</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Phosphorylation regulates FOXC2-mediated transcription in lymphatic endothelial cells</article-title>
<source>Mol Cell Biol</source>
<year>2013</year>
<volume>33</volume>
<fpage>3749</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.01387-12</pub-id>
<pub-id pub-id-type="pmid">23878394</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brice</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mansour</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Collin</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Child</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Brady</surname>
<given-names>AF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24</article-title>
<source>J Med Genet</source>
<year>2002</year>
<volume>39</volume>
<fpage>478</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.39.7.478</pub-id>
<pub-id pub-id-type="pmid">12114478</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brice</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Child</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mansour</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Burnand</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Milroy disease and the VEGFR-3 mutation phenotype</article-title>
<source>J Med Genet</source>
<year>2005</year>
<volume>42</volume>
<fpage>98</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2004.024802</pub-id>
<pub-id pub-id-type="pmid">15689446</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D89 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000D89 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     PMC:4464120
   |texte=   No evidence of locus heterogeneity in familial microcephaly with or without chorioretinopathy, lymphedema, or mental retardation syndrome
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i   -Sk "pubmed:25934493" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024